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ABSTRACT 
Proteomic Analysis of Mammary Epithelial Cell Development 
Alyssa Kay Conly 
In this set of studies, a proteomic approach was used to investigate the protein profile of 
the mammary epithelial cell (MEC) through different stages of mammary development. 
The HC11 cell line was used to investigate protein changes between undifferentiated and 
differentiated MEC, which represent the pregnant and lactating states of the cells. This 
comparison revealed an interesting differential expression profile underscoring many 
recognized processes that occur in differentiated MECs, while others unveiled differences 
between MEC differentiation in vitro and in vivo. Primary MEC were also isolated from 
virgin, pregnant, and primiparous quiescent mice to compare the virgin state of the cell to 
the other two stages of development. These comparisons added to a previous dataset of 
primary isolated MEC and generated data that implied a surprising level of activity in 
virgin MEC relative to the other stages of development investigated. Differentially 
expressed proteins in the virgin and primiparous quiescent comparison also added to 
evidence of persisting changes occurring in the gland after a full term pregnancy that are 
implicated in the risk for breast cancer development. Data sets generated in the same 
manner from differentiating MEC were used in the development of a database to help 
manage the growing list of differentially expressed proteins and aid in the identification 
of potential interesting patterns of regulation during mammary development and 
differentiation.   
	  v 
 
ACKNOWLEDGMENTS 
 
I would like to thank all of my committee members for being so accommodating and 
supportive. Also, I would like to thank my lab-mates Laura Strand and Nicole Einfalt for 
the help provided over the years and for keeping time in the lab entertaining. Marcus 
Zuzow and the students in the Tomanek lab also deserve many thanks for all of the help 
they have provided over the past couple of years. Lastly, I would like to especially thank 
Dan Peterson for all of his guidance and for his contribution to making my experience at 
Cal Poly a wonderful one.  
  
	  vi 
 
TABLE OF CONTENTS 
 
Page 
LIST OF TABLES ............................................................................................................. xi  
LIST OF FIGURES .......................................................................................................... xii  
CHAPTER 1 – Literature Review .......................................................................................1  
1.1 Introduction ........................................................................................................1 
1.2 The Mammary Gland .........................................................................................3 
1.2.1 Anatomy of the fully developed gland ................................................3 
1.2.1.1 Parenchyma ..........................................................................4 
1.2.1.1.1 The alveolus .......................................................4 
1.2.1.1.2 The ductal system ..............................................5 
1.2.1.1.3 The teat ...............................................................7 
1.2.1.2 Stroma ..................................................................................9 
1.2.1.2.1 Extracellular matrix ...........................................9 
1.2.1.2.2 Immune cells ....................................................10 
1.2.1.2.3 Adipocytes .......................................................12 
1.2.1.2.4 Fibroblasts ........................................................13 
1.2.1.2.5 Endothelium .....................................................14 
1.2.2 Developmental events and stages of the mammary gland ................15 
1.2.2.1 Pubertal growth ..................................................................15 
	  vii 
 
1.2.2.2 Virgin adult ........................................................................19 
1.2.2.3 Pregnancy ...........................................................................20 
1.2.2.4 Lactation ............................................................................24 
1.2.2.5 Synthesis of milk components ...........................................27 
1.2.2.5.1 Lactose synthesis .............................................27 
1.2.2.5.2 Lipid synthesis .................................................28 
1.2.2.5.3 Protein synthesis ..............................................30 
1.2.2.6 Involution ...........................................................................33 
1.2.2.7 Quiescence .........................................................................36 
1.2.3 Breast cancer incidence .....................................................................37 
1.3 Bioinformatics ..................................................................................................39 
1.4 Summary ..........................................................................................................41 
CHAPTER 2 – Proteomic Analysis of HC11 Differentiation ...........................................42 
2.1 Introduction ......................................................................................................42 
2.2 Methods............................................................................................................44 
2.2.1 Cell culture ........................................................................................44 
2.2.2 Protein extraction ..............................................................................45 
2.2.3 Two-dimensional gel electrophoresis (2DGE) .................................46 
2.2.4 Gel analysis, spot picking and trypsin digestion ...............................47 
2.2.5 Mass spectrometry and protein identification ...................................48 
	  viii 
 
2.3 Results ..............................................................................................................49 
2.4 Discussion ........................................................................................................56 
2.4.1 Metabolism .......................................................................................57 
2.4.2 Cytoskeleton .....................................................................................61 
2.4.3 Protein biosynthesis and processing .................................................63 
2.4.4 Transcriptional regulation and RNA processing ...............................63 
2.4.5 Comparison to Previous Studies .......................................................64 
CHAPTER 3 – Proteomic analysis of isolated primary virgin, pregnant  
and primiparous quiescent mammary epithelial cells ........................................................68 
3.1 Introduction ......................................................................................................68 
3.2 Methods............................................................................................................70 
3.2.1 Animals and breeding .......................................................................70 
3.2.2 Primary mammary epithelial cell isolation  ......................................71 
3.2.3 Protein extraction ..............................................................................72 
3.2.4 Two-dimensional gel electrophoresis (2DGE) .................................72 
3.2.5 Gel analysis, spot picking and trypsin digestion ...............................72 
3.2.6 Mass spectrometry and protein identification ...................................72 
3.3 Results ..............................................................................................................73 
3.4 Discussion ........................................................................................................82 
	  ix 
 
3.4.1 Virgin vs Pregnant Comparison ........................................................84 
3.4.1.1 Cytoskeleton ......................................................................84 
3.4.1.2 Metabolism ........................................................................85 
3.4.1.3 Protein synthesis and processing .......................................87 
3.4.1.4 Secreted proteins ................................................................88 
3.4.1.5 Other identified proteins ....................................................95 
3.4.2 Virgin vs Primparous Quiescent Comparison ...................................90 
3.4.2.1 Cytoskeleton ......................................................................90 
3.4.2.2 Metabolism ........................................................................91 
3.4.2.3 Protein synthesis and processing .......................................93 
3.4.2.4 Transcriptional regulation and RNA processing ................93 
3.4.2.5 Secreted proteins ................................................................94 
3.4.2.6 Other identified proteins ....................................................95 
3.4.3 Comparison to Previous Studies .......................................................95 
CHAPTER 4 – Development of a database for organization and analysis 
of mammary epithelial cell data: BROVINE .....................................................................98 
4.1 Introduction ......................................................................................................98 
4.2 Methods..........................................................................................................100 
4.2.1 BIO 441 ...........................................................................................100 
4.2.2 CSC 366 ..........................................................................................101 
	  x 
 
4.2.3 Individual database development ....................................................102 
4.2.4 Data Preparation ..............................................................................103 
4.3 Results ............................................................................................................104 
4.4 Discussion ......................................................................................................110 
LIST OF REFERENCES .................................................................................................112 
APPENDIX A – Use Case Document from CSC 366 .....................................................132 
  
	  xi 
 
LIST OF TABLES 
 
Table           Page 
1. List of identified protein spots that were differentially expressed between 
undifferentiated and differentiated HC11 cells ......................................................53	  
2. List of identified protein spots that were differentially expressed between 	  
isolated primary virgin and pregnant MECs ..........................................................78	  
3. List of identified protein spots that were differentially expressed between 	  
isolated primary virgin and primiparous quiescent MECs ....................................80	  
  
	  xii 
 
LIST OF FIGURES 
 
Figure           Page 
1. Fused gel image of HC11 protein spots .................................................................50	  
2. Heat map of differentially expressed HC11 protein spots .....................................51	  
3. Proposed energy metabolism pathways in differentiated HC11 cells ...................52	  
4. Fused gel image of isolated primary mammary epithelial cell protein spots ........75	  
5. Heat map of protein spots that were differentially expressed between 	  
isolated primary MEC from virgin and pregnant mice ..........................................76	  
6. Heat map of protein spots that were differentially expressed between 	  
isolated primary MEC from virgin and primiparous quiescent mice ....................77	  
7. Upload page of the Brovine database ..................................................................104	  
8. Experiment Hierarchy page of the Brovine database ..........................................105 
9. Gene Summary page of the Brovine database .....................................................106 
10. TF Summary page of the Brovine database .........................................................107 
11. Gene Search page of the Brovine database ..........................................................108 
12. TF Subtract page of the Brovine database ...........................................................109
	  1 
 
CHAPTER 1 – Literature Review  
1.1 Introduction 
At the center of milk production lays the secretory mammary epithelial cell (MEC). This 
cell is responsible for the production and secretion of all milk components that are relied 
upon to solely nourish newborn offspring of the Class Mammalia. With changing stages 
of the reproductive life of the female mammal, the role of the mammary gland also 
changes. As the gland prepares for lactation the MEC population must expand and 
develop into cells capable of the metabolic power necessary to fulfill their function. The 
hormonal cues of puberty, pregnancy and lactation influence the development and 
differentiation of the MEC into a milk producing phenotype. Though the changing 
hormonal cues playing a role in the development of the mammary gland are well 
documented, the resulting molecular signals are less understood. This topic is being 
heavily investigated as better understanding of these underlying mechanisms can lead to 
improvements in the dairy industry, breast feeding, and even prevention and treatment of 
breast cancer.  
Approaches to the study of biological science fields, such as mammary development, 
have shifted to the evaluation of whole systems and networks of data at once by 
performing experiments that allow discovery of new molecules and processes instead of 
confirmation or refutation of theories about a specific pathway. The broad topics of study 
focused on whole systems have become to be known as the “-omics.” These studies allow 
the discovery of new investigative topics and the ability to see more factors interacting in 
a system at one time. These methods require collaboration with technology-related fields 
in order to produce computer systems able to manage and analyze the large and complex 
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datasets being generated. An interdisciplinary approach is recognized as essential and is 
being implemented as shown by the emerging field of bioinformatics.  
This review will cover the stages of development of the mammary gland, the mechanisms 
behind its changing phenotype that have been discovered thus far, and importance of the 
emergence of interdisciplinary studies in advancing understanding of systems such as this 
one.  
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1.2 The Mammary Gland  
1.2.1 Anatomy of the fully developed gland 
A unique characteristic of the mammary gland is its ability to repeatedly undergo 
functional differentiation and involution to quiescence throughout the sexually productive 
period in the life of the female mammal. The majority of the gland’s development occurs 
beginning at puberty, but it is not fully developed and functional until the female 
experiences pregnancy and lactation. The gland is comprised of two tissue compartments: 
the epithelial parenchyma and the stroma. This section describes the anatomy and basic 
function of these compartments as they exist in a fully developed mammary gland in 
order to provide understanding of all structures and cells that can be found in the gland. 
The following section will walk through specifics for each stage of mammary gland 
development. 
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1.2.1.1 Parenchyma 
The parenchyma is the tissue of the gland that is responsible for the synthesis, secretion 
and transport of milk to the offspring. Its overall structure resembles a tree branching into 
the bed of the stromal tissue of the gland. This branching structure varies slightly among 
species, but its general components and functions remain the same.  
 
1.2.1.1.1 The alveolus 
When following a drop of milk through the mammary gland from its origin of production 
to its expulsion into the mouth of the offspring, the journey begins in a structure called 
the alveolus, or acinus. Alveoli are small spherical structures made up of a lumen 
surrounded by two different layers of distinct cell types and are often clustered in 
bunches called lobules. Looking from the inside of the lumen, secretory luminal epithelial 
cells are seen lining the inner layer of the alveolus. The secretory MEC are cuboidal to 
columnar in shape and are connected to each other by tight junctions, allowing strict 
control over everything that enters or leaves the lumen of the alveolus. These tight 
junctions change in permeability based on different stimuli, but are impermeable during 
lactation to prevent paracellular leaking in either direction in order to maintain milk 
composition and to allow storage between times of nursing (Nguyen and Neville, 1998; 
Mepham, 1983). These are the functional cells of milk production; secretory MEC are 
responsible for all synthesis and transport of the necessary components into the alveolar 
lumen to create the final product known as milk. The processes underlying synthesis of 
these different milk components by the secretory MEC will be discussed later in this 
chapter.  
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Unseen from the inside, but sprawled around the outside of this layer of secretory cells in 
a pattern resembling a woven basket is the branching basal myoepithelial cell layer. 
Lactating rat mammary glands were found to have 4-6 myoepithelial cells per alveolus 
with each cell having 8-10 terminally branched processes, allowing encompassment of 
the structure (Nagato et al., 1980). These cells resemble smooth muscle cells in their 
filament profile and have the ability to contract in response to the hormone oxytocin, 
causing them to compress the alveolus and force milk out of the lumen into the 
connecting duct (Emerman and Vogl, 1986; Nagato et al., 1980). Myoepithelial cells 
contain gap junctions between each other, most likely for coordination of this contraction 
(Mepham, 1983).  
Though its size may vary, the alveolus is present and similarly structured in mice, cattle 
and humans and performs the same essential functions. 
 
1.2.1.1.2 The ductal system 
When the signal is given by oxytocin, the alveolar myoepithelial cells contract and the 
milk is pushed from the alveolar lumen into the ductal system. The ductal system 
transports the milk unaltered from the site of production to the site of ejection. Smaller 
ducts collect milk from the alveolar lumen and transport it to progressively larger ducts, 
eventually culminating in a single collecting duct that terminates at an orifice in the 
nipple or teat (Mepham, 1983). Arrangement, number and size of the ducts vary with 
species, but the microstructure is conserved.  
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The ducts transporting the milk through the gland are very similar to the alveolus in 
cellular composition. Cuboidal to columnar epithelial cells resembling the secretory MEC 
line the ductal lumen, but these epithelial cells do not produce and secrete milk 
components like those of the alveoli (Hassiotou and Geddes, 2013). Tight junctions are 
still present and very important in the ductal lumen in order to maintain the pressure 
needed to transport and eject the milk from the gland as well as prevent any movement of 
material in and out of the ductal system through the paracellular route (Nguyen and 
Neville, 1998).  
A myoepithelial layer also surrounds this layer of non-secretory luminal epithelial cells. 
Unlike the branching basket-like pattern of the alveolar myoepithelium, the cells of the 
duct are long and narrow in shape, arranged parallel to the direction of milk flow through 
the duct. Contraction of these cells results in a decrease in length and increase in diameter 
of the duct, allowing the quick movement of a larger volume of milk through the gland 
and to the nipple for ejection in response to the oxytocin cue (Emerman and Vogl, 1986).  
Ductal microstructure and function is conserved greatly across species, but patterns of 
branching and numbers of ducts vary among them. Female mice have only one ductal 
opening at each nipple. Each duct divides into secondary ducts and forms a branching 
tree network ending in clusters of alveoli, but all milk produced in each gland culminates 
into the single lactiferous duct leading to each nipple (Cardiff and Allison, 2012). Like 
the female mouse, the cow has a branching epithelium draining into only one lactiferous 
duct leading to each teat. While the mouse and the human have ducts with relatively 
constant diameter leading up to the point of milk ejection and little room in the way of 
milk storage, the cow has an enlargement in the diameter of the duct where the milk from 
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all the branches collects prior to the duct orifice. This enlarged portion of the duct is used 
for milk storage and is called the gland cistern (Reece, 2009). Unlike the cow and mouse, 
the human has multiple ducts associated with a single mammary gland reaching the 
surface of each nipple. Each duct leads to a completely separated branching lobe of the 
mammary gland divided by fibrous stroma. The number of ducts and lobes per human 
breast varies greatly among individuals, where the most recent data reports an average of 
nine fully functional lobes with ducts opening to the surface (Ramsay et al., 2005; 
Gooding et al., 2010; Hassiotou and Geddes, 2013). While they vary in organization, the 
ducts for all three have their individual benefits and satisfy the purpose of the ductal 
system, which is transport of the final unaltered milk product from the site of production 
to the site of ejection. 
 
1.2.1.1.3 The teat 
After its journey through the ducts, the milk arrives at the nipple or teat where the 
offspring can latch on and consume the ejected milk from the gland. Though not truly 
considered part of the parenchyma, the nipple plays a large role in the final step of milk 
delivery to the young and warrants discussion alongside the parenchymal components. 
This region is characterized by an outside covering of hairless epidermis formed around 
the orifice of the lactiferous duct, or ducts (Koyama et al., 2013). Smooth muscle is also 
found in the region near the epidermis and near the ducts and is important for the 
protrusion of the nipple to allow latching of offspring and for sphincter like function to 
prevent milk escaping from the teat between times of nursing (Hassiotou and Geddes, 
2013).  
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Not only is this the site of milk expulsion and structurally important for the delivery of 
milk to offspring, but it is the site of afferent nerve endings that influence every event in 
the process of nursing young. Stimulation of these nerves causes release of oxytocin 
which cues the contraction of myoepithelium, as well as the release of prolactin, whose 
effects will be further covered later in this chapter (Koyama et al., 2013). 
The nipples, or teats, of mammals vary in number and shape among species determined 
by the need of the offspring. Female mice have ten total nipples, each associated with its 
own mammary gland. They are positioned in pairs along the ventral portion of the mouse 
with three in the pectoral region and two in the inguinal region (Koyama et al., 2013). 
Cows have four total teats, also each associated with its own gland. They are positioned 
in the udder as two pairs, located in the inguinal region of the cow (Reece, 2009). 
Humans have only two nipples, each also associated with its own gland. As mentioned 
previously, each gland consists of multiple completely separated lobes that have 
individual openings at the same nipple, but they are still collectively considered a single 
gland. Position of the human glands exists as one pair in the pectoral region (Koyama et 
al., 2013). 
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1.2.1.2 Stroma  
Parenchyma may produce and secrete and transport the milk components, but without the 
stroma the mammary gland would not be able to fully develop and carry out its intended 
function. As has been covered several reviews, stromal tissue of the mammary gland 
provides structural support for glandular tissue and delivers essential growth factors and 
hormones that direct the development and maintain the structure and function of the 
gland (McCave e al., 2010; Hovey et al., 1999). Components of the stroma include the 
extracellular matrix (ECM), adipocytes, immune cells, fibroblasts, and the endothelium. 
Each of these components varies in abundance and organization among species, but they 
all play an important role in the development and function of the mammary gland. 
 
1.2.1.2.1 Extracellular matrix  
The ECM is not a cellular component itself but is essential for and isproduced by the cells 
of the mammary gland. The ECM is composed of macromolecules secreted by the cells 
of the connective tissue and MEC. Glycosaminoglycan and fibrous proteins such as 
collagen, elastin, and laminin are the major components forming the matrix. The 
composition and organization of the matrix is constantly in flux and maintained by the 
cells of the stroma in response to released factors as well as mechanical stress (Alberts et 
al., 2002). Different regions of ECM are composed of different proportions of the 
mentioned proteins because of the role it needs to fill and the cell types present that are 
responsible for secreting the components (Maller et al., 2010). In humans and cows the 
ECM, along with fibroblasts, creates a thick fibrous layer separating the adipose tissue 
and parenchyma of the mammary gland and is extensive between and within the lobules 
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in these species to help provide extra support and maintain the form of these glands due 
to their size and placement (Hovey et al., 1999). 
In addition to providing structural support to the parenchyma by allowing attachment and 
stability, the ECM has also been implicated in apoptosis, proliferation, branching, cell 
polarity and differentiation. The proteins of the ECM serve as signaling molecules in 
signal transduction pathways as well as mechanotransducers by connecting the ECM to 
the cytoskeleton of the cells (Butcher et al., 2009). Growth factors and cytokines are also 
bound to the proteins of the ECM, whereby it can serve as a reservoir for the 
sequestration of signaling molecules in specific locations for different purposes such as 
directing ductal growth during development or recruiting immune cells which are present 
and active in all stages of development (Maller et al., 2010).  
 
1.2.1.2.2 Immune cells  
Cells of the immune system are present and active throughout mammary development 
and function. Branching morphogenesis, terminal end bud (TEB) formation and ductal 
outgrowth are impaired without the presence of mast cells, macrophages and eosinophils. 
Lilla and Werb demonstrated decreased cell proliferation and impaired mammary 
development in mice deficient in or lacking mast cells (2010). Mast cells were seen 
concentrated near or ahead of the TEB in developing murine mammary glands. It was 
determined that mast cells most likely function in development by contribution of some 
component released during degranulation. Though uncertainty surrounding their exact 
function in development persists, it is speculated that released proteases or other factors 
aid in angiogenesis, remodeling the ECM or activating other proteases. Macrophages and 
	  11 
 
eosinophils are also known to exist in close proximity to the TEB during branching 
morphogenesis and ductal outgrowth and are necessary for normal development. 
Depletion of these cells resulted in the complete absence of TEBs and stunted ductal 
outgrowth (Gouon-Evans et al., 2002, 2000). Macrophage-specific depletion showed 
defective TEB formation and reduced ductal outgrowth indicating a role in these 
processes, probably accomplished by phagocytic activity and trophic factor release 
(Gouon-Evans et al., 2000). Eosinophil-specific depletion resulted in decreased number 
of branches indicating a role in branching of the ducts, possibly carried out by release of 
TGF-β or other factors (Gouon-Evans et al., 2000). 
Development during pregnancy and lactation also requires the influence of immune cells. 
A need for colony stimulating factor 1 (CSF-1) has been described in the development of 
a properly functioning lobulo-alveolar system; in addition to a reduced number of 
macrophages, CSF-1 deficient mammary gland resulted in the inability to switch to the 
lactating phenotype, suggesting a possible role for macrophages in this process (Pollard 
and Henninghausen, 1994). In addition to the development, plasma cells are recruited to 
the mammary gland during lactation and are essential for production of antibodies that 
are incorporated into the milk by the epithelial cells. IgA is the primary antibody 
produced in the mammary gland and is found in the milk of mice, cattle and humans. 
Other antibodies are transferred into the milk from the blood including the main antibody 
present in bovine colostrum, IgG (Weisz-Carrington et al., 1977; Hunziker and 
Kraehenbul, 1998; Bourges et al., 2008). Production and delivery of these antibodies 
through the milk is essential to the first defense of the offspring. 
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In addition to the developmental functions mentioned above, the immune cells of the 
mammary gland are also fulfilling their most well known function of scouting the gland 
for infiltrators and keeping the tissue and the milk free from infection (Stelwagen et al., 
2009). 
 
1.2.1.2.3 Adipocytes  
The mammary gland of the mouse contains a far higher proportion of adipocytes than the 
cow or human (Hovey et al., 1999). Many of the studies investigating the roles of these 
adipocytes have been performed with mice; applying conclusions from results across 
species should be implemented with caution. Though previously thought to play little role 
in the development and function of the mammary gland, essential functions of the 
mammary adipocytes have been unveiled, as nicely outlined in a recent review (Hovey 
and Aimo, 2010). Adipose tissue has been acknowledged as an indispensable component 
of the mammary stroma.  
Of the many roles the adipocytes play in the gland, one is provision of nutrient 
components to the epithelial cells to aid in milk production during lactation. Depletion of 
the fat stores in adipocytes in the lactating mammary gland has been observed and is 
believed to provide fatty acids to the epithelium (Elias et al., 1973; Clegg, 1981), though 
it is believed that only a small proportion of the fatty acids needed by the MEC are 
supplied by the adipocytes (Neville et al., 1998). The rest would be synthesized in the 
MEC or delivered through the blood from diet or other fat deposits. Adipocytes 
themselves have also been found to release lipoprotein lipase into the circulation of the 
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mammary gland to breakdown TAG from the blood into fatty acids for the parenchyma to 
utilize to for milk component synthesis (Jensen et al., 1994). 
In addition to providing nutrients, adipocytes have the ability to produce a multitude of 
paracrine and endocrine factors including growth factors and hormones. Among these 
molecules produced is the hormone prolactin, which was previously thought to have the 
sole production center in the anterior pituitary gland. This has been found true in humans 
and mice, though its autocrine or paracrine role has not been confirmed as necessary 
(Zinger et al., 2003). Potential for estrogen production in the mammary adipose due to 
expression of aromatase has also been found, which was shown to be prolactin-inducible 
in bovine mammary adipose cultures (Feuerrman et al., 2009). Many growth factors are 
also produced by the adipocytes of the mammary gland such as insulin-like growth factor 
1 (IGF-1), transforming growth factor-β (TGF-β), and vascular endothelial growth factor 
(VEGF), which take part in development of the glandular epithelium, response to 
hormone activation, and development of the mammary vasculature, respectively.  
 
1.2.1.2.4 Fibroblasts 
Fibroblasts are the major cells of connective tissue and secrete the components making 
up much of the ECM, including production of components in the basement membrane 
such as laminin, nidogens, and collagen. The ECM, as mentioned above, is essential for 
support of the glandular tissue and proper development and function of the mammary 
gland; presence of some of these components has been shown necessary for polarization 
and differentiation of mammary epithelium (Luhr et al., 2012). Fibroblasts are also 
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responsible for the secretion of growth factors and matrix metalloproteinases that play 
roles in multiple stages of mammary development (Simian et al., 2001). 
 
1.2.1.2.5 Endothelium 
Vascularization of the mammary gland is present throughout the development of the 
organ, with vast expansion occurring during pregnancy and regression at involution 
(Andres and Djonov, 2010). Endothelial cell precursors are recruited from the bone 
marrow or created from resident pluripotent stem cells in the tissue to form and remodel 
microvasculature during pregnancy by the influence of hormones such as estrogen 
(Kabmeyer et al., 2009; Cid et al., 2002). During pregnancy and lactation, the 
endothelium is organized in capillaries enveloping each individual alveolus and the 
capillaries become more permeable to enable efficient nutrient transfer (Djonov et al., 
2001; Abdul-Awal et al., 1996). In humans it was found that relatively large and few 
sinusoidal shaped capillaries encircle each alveolus to allow slow movement of blood and 
ensure transport of essential nutrients and hormonal signals to the alveolar cells 
(Naccarato et al., 2003). The major known molecule playing a large role in vasculature 
forming and remodeling during pregnancy is VEGF, which has been shown to be 
inducible by estrogen and is secreted by the epithelium and other cells of the stroma 
(Rabbany et al., 2003; Hovey et al., 2001; Andres and Djonov, 2010). 
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1.2.2 Developmental events and stages of the mammary gland. 
1.2.2.1 Pubertal growth 
Until puberty the mammary gland undergoes isometric growth, at which time females 
experience allometric growth of the gland in response to changing hormone levels. A rise 
in gonadotropin releasing hormones from the newly mature hypothalamic-pituitary-
gonadal axis at the onset of puberty causes production of ovarian hormones (Howlin et 
al., 2006; Plant and Barker-Gibbs, 2004). The production and release of these hormones 
cause the outgrowth of the mammary ductal tree into the surrounding stroma.  
In the rodent, highly proliferative bulb-shaped structures called terminal end buds (TEB) 
are formed in the parenchyma and lead the ducts as they extend through the existing fat 
pad. The TEB is made up of different layers of epithelial cells with the outermost layer 
being made up of a stem cell population referred to as the cap cells. These cells line the 
outside of the TEB from the leading edge into the neck region of the structure and are 
continuous with the differentiated myoepithelial layer of the duct, as these cap cells 
eventually give rise to the myoepithelium (Richert et al., 2000; Williams and Daniel, 
1983). At the trailing edge of the TEB, the differentiated myoepithelial cells produce 
basement membrane surrounding the duct while the fibroblasts of the fat pad secrete 
other components of the stroma surrounding the membrane (Daniel and Silberstein, 1987; 
Williams and Daniel, 1983). This outside layer of cap cells surrounds several layers of 
epithelial cells referred to as the body cells. These cells eventually become the ductal 
epithelial cells (Daniel and Silberstein, 1987). The innermost layer of body cells 
undergoes apoptosis in order to form the lumen of the duct; in fact, the levels of apoptosis 
observed in the TEB during ductal expansion (11.3%) are higher than observed levels in 
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any other stage of mammary development, including involution (4%; Quarrie et al., 1995; 
Humphreys et al., 1996). Bifurcation of the TEB allows for full outspread to the edges of 
the fat pad. Though it is difficult to study pubertal development of the mammary gland in 
humans, it appears that there are also end bud-like structures leading the expansion of the 
ducts during this period of outgrowth, though cap cells like in rodent TEB have not been 
identified (Howard and Gusterson, 2000). Bovine mammary glands are a bit different in 
their structure and timing of outgrowth with a central, solid epithelial cord surrounded by 
5-10 ductal outgrowths called a terminal ductal unit (TDU) that influence allometric 
growth prior to puberty. The whole unit invades the stroma together and the lumen does 
not appear to be created by high levels of apoptosis as has been determined in the rodent 
gland (Capuco and Ellis, 2005). Hormone levels, the hormone receptor profile of 
different cell types, and growth factors within the mammary gland dictate these patterns 
of growth. 
Among several hormones affecting this surge in growth, estrogen (E) has the primary 
effect.  Estrogen receptor α (ERα) is essential for ductal outgrowth during pubertal 
development, while ERβ doesn’t seem to play a role (Mallepell et al., 2006). Presence of 
ERα in the mammary epithelium was shown to be necessary for this development while 
its presence in the stroma did not affect the ductal outgrowth (Mallepell et al., 2006). 
Cells devoid of ERα were shown to proliferate - in fact, in rodents and humans 
proliferating cells rarely contain steroid receptors (Clarke et al., 1997; Russo et al., 1999). 
It is thought that E exerts its effects in a paracrine manner, acting only on a subset of cells 
in the mammary epithelium which then produce and secrete additional factors that act on 
other epithelial cells directly, or on stromal cells, also causing release of growth factors 
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that would influence epithelial outgrowth. Amphiregulin (AREG) is thought to be the 
molecule responsible for mediating this response to E. Its receptor, epidermal growth 
factor receptor (EGFR), is necessary in the fat pad for normal development and stromal 
cells secrete growth factors in response to this molecule (Wiesen et al., 1999; Sternlicht et 
al., 2005). Though the increase of ovarian E at puberty is of utmost importance, it is well 
documented that the presence of a certain pituitary hormone is essential for ductal 
outgrowth as well (Sternlicht, 2005).  
Growth hormone (GH) is also necessary for ductal outgrowth during puberty. It is 
thought to influence the formation of the TEB that begins invading the mammary stroma 
(Kleinberg, 1997). Growth hormone is produced by the anterior pituitary and acts on the 
stroma of the mammary gland to induce expression of ER and insulin-like growth factor 
1 (IGF-1). This locally produced factor then acts on the MEC to induce formation of 
TEB, and proliferation and outgrowth of the ductal system, which without the ability to 
respond to IGF-1 does not occur (Walden et al., 1998; Wood et al., 2000; Hadsell and 
Bonnette, 2000). Estrogen acts synergistically with GH and IGF-1 to allow proper 
outgrowth and development of the pubertal gland (Kleinberg, 1997; Ruan et al., 1995).  
Far less credit has been given to other hormones and steroid receptors, and while E and 
GH remain to be considered the hormones most involved in ductal outgrowth during 
puberty, a few others have been implicated in the regulation of this process as well and 
should be given an honorable mention. Though little evidence has been found for a large 
role for progesterone (P) in the pubertal mammary gland, it has been shown that pubertal 
branching is delayed when PR is antagonized (Shi et al., 2004) and it was recently shown 
that progesterone might also work through AREG to aid in ductal growth and branching 
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in the pubertal gland (Auperlee et al., 2013). Though these new functions are being 
uncovered, the largest role P plays still occurs during pregnancy. Knockout of the 
glucocorticoid receptor has also caused abnormal development during puberty, though 
this is difficult to properly study because of the necessity of transplanting mammary 
tissue from the embryo into fat pads due to lethal consequences of the deletion (Kingsley-
Kallesen et al., 2002). In contrast to these previous two, the vitamin D3 receptor (VDR) 
seems to aid in the repression of ductal outgrowth. Mice with VDR knockouts displayed 
accelerated outgrowth and ductal branching during puberty (Zinser et al., 2002). It is 
speculated that E causes transcription and translation of VDR, which appears to 
antagonize the proliferation of the epithelium, possibly through the regulation of the ER 
itself (Byrne et al., 2000; Welsh et al., 2003; Howlin et al., 2006).  
In addition to hormones and steroid receptors, additional locally produced growth factors 
much like IGF-1 also play a role in directing and regulating mammary ductal outgrowth. 
Due to the focus of this review, these factors will not be discussed but their important 
roles in development are continuously being discovered. These include factors such as 
epidermal growth factor, TGF-β, and hepatic growth factor. This list is not exhaustive 
and full understanding on their effects of the gland and its development has not been 
achieved. While it is clear that E and GH drive the outgrowth and development of the 
epithelium, the regulation of proper growth and development during puberty is optimal 
when many different hormones, receptors and factors are present and working together in 
harmony.  
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1.2.2.2 Virgin adult 
Terminal end buds of the developing ducts of the mammary gland have reached the 
borders of the fat pad and regressed to non-motile units by the end of puberty. Although 
full development and capacity to secrete milk components does not occur until 
pregnancy, changes in the gland occur with every estrous cycle. Tertiary side branches 
begin to expand within the stroma between developed ducts and acini and show 
development and regression with the cyclic production of different ovarian hormones 
(Daniel and Silberstein, 1987). In both rodents and humans the mammary epithelium 
cycles through stages of proliferation, differentiation and apoptosis that mirror the 
hormone changes through the estrous cycle. Peak proliferation of MEC occurs during 
metestrus and diestrus-1 in rodents and the equivalent, late luteal phase, in humans 
(Schedin et al., 2000). Peak differentiation has been seen during the same time period of 
luteal phase and metestrus/diestrus-1, as measured by beta-casein and whey acid protein 
mRNA levels throughout the cycle (Schedin et al., 2000). Lastly, apoptosis levels were 
elevated and suppressed at similar points in the cycles of rodents and humans. Apoptosis 
was found to be much more variable than proliferation but was seen to be suppressed 
during times of peak proliferation and increased during proestrus and diestrus-2 (Schedin 
et al., 2000). Although they are continuously developing, the alveolar development never 
reaches near the level of differentiation of pregnancy. 
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1.2.2.3 Pregnancy 
Though developing and regressing with each estrous cycle during the gland’s nulliparous 
adult existence, the gland does not begin down the path of full development until 
conception. Prior to conception, the gland has branched via TEBs to the ends of the 
mammary fat pad and lacks only the extensive side branches and alveoli that are seen in a 
lactating mammal. After conception, the ovum implants in the uterus and causes 
hormonal changes that alert the body of pregnancy. In the human, cells that are destined 
to be the placenta begin producing human chorionic gonadotropin (hCG), which is 
responsible for the maintenance of the corpus luteum and its continued P and E secretions 
during early pregnancy. In rodents, prolactin (PRL) secretions are responsible for this 
early corpus luteum maintenance (Neville et al., 2002). The lengthened survival of the 
corpus luteum allows for its further production of P and E, which cause side branching 
and alveologenesis in the mammary gland and production of PRL from the anterior 
pituitary, respectively. At mid pregnancy placental lactogen takes over this role of corpus 
luteum maintenance in rodents while in humans, the placenta itself begins to produce the 
required hormones for maintenance of pregnancy and mammary development (Neville et 
al., 2002). While E induces expression of PR and PRLR in the mammary epithelium as 
well as production of PRL from the anterior pituitary, P and PRL work together to 
prepare for lactation. Both P and PRL each induce the expression of the other’s receptor 
and individually work in a paracrine fashion, recruiting other factors to signal for ductal 
side branching, proliferation and MEC differentiation (Brisken et al., 1999; Edery et al., 
1985; Sakai et al., 1979). 
Progesterone acts through progesterone receptor B (PRB) to elicit responses related to 
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mammary development; it has been found responsible for side branching and mitotic 
activity of the epithelium during pregnancy (Brisken et al., 1998). As the majority of 
proliferating cells are PR negative, the possible paracrine activation of these cells has 
received much attention. Investigations into this topic are far from over, but candidate 
pathways have been proposed. Wnt-4 was the first proposed mediator of P action in the 
mammary gland. Brisken and colleagues showed that P induces Wnt-4 expression during 
early pregnancy and that it is capable of causing side branching in the mammary 
epithelium (2000) and Ramamoorthy and colleagues showed that Wnt-4 is a direct 
transcriptional target of PR (2010). Whether it causes a response in neighboring cells 
remains to be determined. Receptor activator of NF-κB-ligand (RANKL) and its 
receptor, RANK, are the strongest current candidates for the paracrine mediators of P 
action. Investigation into this factor began when Fata and colleagues discovered that mice 
lacking RANKL or its receptor failed to develop alveolar structures during pregnancy 
(2000). Since this discovery, RANKL has been found to be stimulated by P as well as 
have the ability to induce Elf5 expression (Beleut et al., 2010). This was particularly 
interesting because Elf5 has been found necessary for successful alveolar morphogenesis 
and lactation (Oakes et al., 2008; Choi et al., 2009). Elf5 and PR expression were found 
to be mutually exclusive so Lee and colleagues proposed that RANKL acts as a paracrine 
mediator for P in order to induce Elf5 (2013). RANKL is also thought to mediate a 
proliferation response to P in neighboring PR negative cells by inducing cyclin D1 
expression (Fernandez-Valdivia et al., 2009). As this information is very recent, there is 
still much to learn about the intracellular signaling resulting in developmental changes in 
response to PR activation, but light has been shed on the role P has on development 
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during pregnancy and possible mediators of this response. In addition to P, PRL has an 
equally important role during pregnancy. 
Prolactin and its receptor are necessary for normal alveolar development, full 
differentiation of the mammary epithelium, and successful lactation following parturition 
(Ormandy et al., 1997). Prolactin binds the prolactin receptor (PRLR), which activates 
the Janus kinase/signal transducer and activator of transcription (JAK/STAT) and protein 
kinase B (PKB/Akt) pathways. Through these pathways PRL affects structural 
development of the mammary gland during early pregnancy and production of milk 
components during late pregnancy and lactation. Signal transducer and activator of 
transcription 5 (STAT5) is a transcription factor in the PRLR/JAK/STAT pathway whose 
phosphorylated state can activate transcription of several genes involved in processes 
important for epithelial cell differentiation such as polarity establishment, epithelial cell-
cell and epithelial-stromal interactions, and milk protein production (Oakes et al., 2006). 
Alveolar defects are seen in   STAT5-/- mice and complete absence of alveolar structures 
and beta-casein is seen in PRLR-/- mice after full term pregnancy (Liu et al., 1997; 
Brisken et al., 1999). Much overlap has been seen in the intracellular signaling cascades 
that result from PR and PRLR activation. As stated above, PR can induce expression of 
Elf5 through RANKL. Elf5 seems to have the ability to induce expression of STAT5 and 
inhibit members of the suppressor of cytokine signaling (SOCS) family, which are 
inhibitors in the JAK/STAT phosphorylation pathway. Induction of Elf5 expression 
would both cause production of STAT5 and allow increased phosphorylation of this 
molecule by JAK in the PRLR/JAK/STAT pathway (Choi et al., 2009). There are 
conflicting studies that report whether or not PRLR might also induce RANKL through 
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the JAK/STAT pathway and play a role in activating Akt pathways that decrease 
apoptosis and delay involution (Srivastava et al., 2003; Brisken et al., 2002). Another 
molecule speculated to play a role in PRLR signaling is IGF-2. Activated PRLR induces 
expression of IGF-2, which in turn causes activation of cyclin D1 and MEC proliferation 
(Hovey et al., 2003; Brisken et al., 2002). Though details still need to be clarified and 
confirmed, it has been revealed that both PRL and its mediators are required for normal 
alveologenesis and roles for these individual mediators are starting to be uncovered.  
Both P and PRL are necessary for the massive proliferation and differentiation seen in the 
beginning stages of pregnancy to prepare for mass production of milk components, but 
their roles shift in the later stages of pregnancy prior to parturition and lactation. 
Progesterone suppresses milk secretion during this time while PRL leads to STAT5 
induction of milk component expression in the differentiating cells. The removal of the 
progesterone signal along with high levels of PRL is what eventually allows for lactation 
(Neville et al., 2002; Anderson et al., 2007). During the withdrawal of P in the MECs, 
colostrum is produced with the transport of immunoglobulin and transferrin in addition to 
other milk components prior to parturition (Neville et al., 2001). 
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1.2.2.4 Lactation 
Due to the influences of PRL and P during pregnancy, the mammary tree is complete at 
the time of initiation of lactation. Primary ducts and side branches have filled the fat pad, 
which now contains large, fully developed alveoli that are already producing milk 
components (Anderson et al., 2007). Initiation of lactation occurs around the time of 
parturition in response to dropping levels of P. In rodents and cows, the level of P sharply 
decreases and PRL levels spike just prior to parturition, so they are fully lactating when 
the offspring are born. The level of P in humans does not fall until after parturition, at 
which point it drops 10-fold in 4 days. The concentration of PRL is already high in 
humans at parturition as it continuously increases during pregnancy (Neville et al., 2001; 
Anderson et al., 2007). The placenta and corpus luteum are no longer producing P; the 
main players from the endocrine system are now the pituitary hormones PRL and 
oxytocin with the help of a few others to drive metabolic processes (Fendrick et al., 
1998).  
When stimulated during suckling, the nerve endings at the tip of the nipple send signals 
to the central nervous system to order the release of hormones including PRL and 
oxytocin from the pituitary gland (Koyama et al., 2013). Prolactin acts on the secretory 
MEC to stimulate continued milk production and secretion while the oxytocin causes 
contraction of the myoepithelium leading to the transport of the milk from the alveoli, 
travel through the ducts, and ejection to the offspring. As long as suckling and initiation 
of this mechanism is continued, oxytocin continues to eject the milk and PRL elicits its 
production. Though PRL is thought to be the main hormone of milk production, other 
hormones have been implicated as having a role in the process.  
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There has been some speculation about the roles of insulin, cortisol, thyroid hormone and 
growth hormone (GH) in governing lactation alongside the influence of PRL. Though 
initially thought to help the mammary gland increase milk production directly, insulin 
levels were found to be low in most lactating animals, which is thought to aid the 
mammary gland in a different way – by discontinuing normal storage mechanisms and 
help mobilize energy stores from other parts of the body to provide the mammary gland 
nutrients for milk production (Vernon, 1989; Neville et al., 2002). Although low levels 
appear to help mammary milk production, the presence of some insulin is necessary for 
transcription of milk proteins (Trott et al., 2012). Cortisol appears to be elevated in dairy 
cattle and rodents during lactation, but often at low levels in lactating women. Since it is 
responsible for maintaining blood glucose it has been speculated that this is the case due 
to energy store depletion and nutrient availability during lactation of the different species 
rather than a direct effect on the mammary gland (Neville et al., 2002; Feng et al., 1995; 
Butte et al., 1999).  Thyroid hormone has been shown to be important for the MEC 
responsiveness to PRL and GH, but has not gained much attention in the recent years 
(Capuco et al., 1999). Receptors for GH have been found on the mammary epithelium 
and in the stroma in both types of animal, so it has the ability to act directly on the MEC 
and can influence milk production by causing expression of IGF-1 both in the mammary 
stroma and the liver, which can then act directly on the MEC. Growth hormone has 
proven to be more influential on ruminant lactation after the beginning stages than it 
appears to be in rodents (Vernon, 1989). Exogenous GH increases milk yield in cattle, 
which has led to its controversial use in the dairy industry for increased product (Bauman 
and Vernon, 1993; Neville et al., 2002). Inhibition of GH in rodents has been shown to 
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slightly reduce milk yield (Flint and Vernon, 1998), but even though GH and PRL have 
very similar receptors and elicit similar effects, PRL is still considered the most 
influential of the hormones in milk production. Prolactin inhibition at the onset of 
lactation greatly affects milk production in many species, including cattle (Karg and 
Schams, 1974; Neville et al., 2002). Though the detailed intracellular signaling involved 
in the influence of PRL on milk production is not well known, its role in milk protein 
synthesis, production of lipogenic and glycolytic enzymes, transporter expression, and 
lipid droplet formation has been shown and is being continuously investigated (Rudolph 
et al., 2011). Phosphorylated STAT5 and Akt1 are thought to play major roles in the 
transcription of many of the genes involved in synthesis of milk components (Anderson 
et al., 2007; Liu et al., 1997) and recent links between STAT5 and Akt1 have been found, 
though the specifics of these links are variable (Chen et al., 2010; Creamer et al., 2010; 
Chen et al., 2012). One link between the two showed that STAT5 induced expression of 
Akt1, which aided in cell survival and delayed involution during lactation. The specifics 
of all the intracellular mechanisms behind inducing the production of milk are still being 
investigated, but the components of milk and the metabolism of these products are 
relatively well understood. 
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1.2.2.5 Synthesis of milk components 
Milk contains all of the necessary nutrients for the offspring to survive and grow. These 
include carbohydrate primarily in the form of lactose, lipids primarily in the form of 
acylglycerol, a variety of proteins including the major milk proteins, caseins and whey 
proteins, vitamins and minerals, and water. There are a huge variety of molecules present 
in milk so only the major constituents will be further discussed. All of these components 
are synthesized and secreted, or transported from the blood to the milk, by the secretory 
MEC lining the lumen of the alveoli. Specifics of the synthesis and secretion of these 
components including a mention of any known hormonal influence on their regulation 
will be covered in the following text. 
 
1.2.2.5.1 Lactose synthesis 
Lactose is the primary carbohydrate found in the milk of most mammals and is the major 
osmotic constituent responsible for drawing water into the final product of milk. Water 
makes up the majority of milk, with all other components being dissolved or suspended 
in it. Lactose concentration is rather constant within a species and relatively constant 
across species when compared with other milk components. In humans, cattle and mice 
lactose makes up approximately 7%, 5%, and 2.5% of milk, respectively (Jenness, 1974; 
Gors et al., 2009; Johnson et al., 2001). Synthesis of lactose is unique to the secretory 
MEC and is carried out by the enzyme lactose synthetase. Lactose synthetase is made up 
of galactosyltransferase and its cofactor, α-lactalbumin, which is also a secreted milk 
protein. Expression of both of the enzyme’s subunits can be induced by PRL and there is 
evidence that insulin is necessary for expression of α-lactalbumin (Palmiter, 1969; 
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Turkington et al., 1968; Rosen et al., 1999). This enzyme catalyzes the reaction between 
UDP-galactose and glucose to create lactose and UDP (Kuhn et al., 1980). As even UDP-
galactose is derived primarily from glucose in the secretory MEC, glucose is necessary 
and in high demand for lactose synthesis (Faulkner and Peaker, 1987). A glucose 
transporter independent of insulin regulation is responsible for maintaining a high 
glucose concentration within the cell as well as allowing glucose into the Golgi 
compartment to support lactose synthesis; this transporter is GLUT1 and its expression is 
increased under the influence of PRL during lactation. Its location on the Golgi 
membrane is unique to the secretory MEC (Nemeth et al., 2000; Anderson et al., 2007).  
Glucose is in high demand in the secretory MEC during lactation for the synthesis of 
milk components other than just lactose. 
 
1.2.2.5.2 Lipid synthesis 
Triacylglycerol (TAG) makes up 98% of the fat in milk (Anderson et al., 2007; Jenness, 
1988), while total fat in milk varies among species ranging from nearly 0% up to around 
50%. Humans and cattle produce milk with an average of 4% fat while mice produce 
milk with approximately 20% fat content (Neville and Picciano, 1997; Gors et al., 2009; 
Johnson et al., 2001). Milk fat content can also largely vary within species dependent on 
body condition, diet, and stage of lactation (Neville and Picciano, 1997). Triacylglycerol 
is made up of a glycerol backbone esterified to three fatty acids (FA). Fatty acids are 
either transported into the cell from adipose stores, supplied by diet, or synthesized de 
novo in the MEC from glucose, amino acids, or in the case of ruminants, acetate. 
Composition and source of FA can also vary with species, diet and body condition. Long 
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chain FA are typically delivered to the cell by albumin carriers and lipoproteins or in the 
form of TAG from the diet or lipid stores of the body via the blood in which it is broken 
down by lipoprotein lipase into FA and glycerol before being taken up into the MEC. 
Medium chain FA are synthesized in the MEC from glucose in nonruminants, or acetate 
in ruminants, or amino acids in both and their levels are reduced if high dietary fat is 
present (Neville and Picciano, 1997; Anderson et al., 2007). Unlike in nonruminants, 
short chain FA are synthesized de novo and found in ruminant milk (Knight and Beever, 
1994; Neville and Picciano, 1997). Glycerol-3-phosphate is used as the glycerol 
backbone to which the FA attach and form TAG. It is either transported into the cell from 
the blood in the form of glycerol, which is then phosphorylated, or it is synthesized from 
dihydroxyacetone phosphate (DHAP), which originates from glucose (Salway, 1994; 
Anderson et al., 2007). Glucose also contributes to NADPH production. Fatty acid 
synthesis requires NADPH as a reducing agent whether they are being synthesized from 
acetate or glucose precursors. NADPH can be generated through different pathways that 
vary with species. Non-ruminants can generate NADPH through the malate/pyruvate 
pathway, the isocitrate pathway, or through the pentose phosphate shunt (PPS). The 
conversion of malate to pyruvate by malate dehydrogenase generates NADPH and allows 
pyruvate to re-enter the TCA cycle. Ruminants lack this ability as they have very low 
malate dehydrogenase and citrate lyase activity. Ruminants do have high isocitrate 
dehydrogenase activity and NADPH can also be generated by the conversion of isocitrate 
to α-ketoglutarate by this enzyme (Ingle et al., 1972). The last method of NADPH 
generation is by glucose shuttling into the PPS. It enters the PPS as glucose-6-phosphate 
(G6P) and can then re-enter the glycolytic pathway as G6P after passing through the 
	  30 
 
shunt (Salway, 1994). Prolactin inhibition causes levels of lipoprotein lipase, lipogenic 
and glycolytic enzymes and enzymes involved in the PPS to fall significantly, indicating 
that this hormone plays a regulatory role in lipid synthesis in the MEC (Rudolph et al., 
2011). 
 
1.2.2.5.3 Protein synthesis 
Protein synthesis occurring in the MEC must support both milk protein generation and 
generation of proteins responsible for maintaining the cell and for producing and 
transporting other milk components. Protein constitutes approximately 0.9%, 3.5%, and 
12% of milk in humans, cattle, and mice, respectively (Jensen, 1995; Lonnerdal, 1985; 
Gors et al., 2009; Boumahrou et al., 2009). Major milk proteins serve as carriers for 
necessary vitamins and minerals, act as antimicrobials, anti-inflammatories, antioxidants 
and specific immune protection, and serve as peptide and amino acid sources to the 
growing offspring. Hormones and growth factors are also present in the milk, which are 
thought to have possible roles in the neonate as well (Thompson et al., 2009). There are 
two classifications of protein in milk: the caseins and the whey proteins. Caseins are 
proteins that are insoluble in acidic pH range, while whey proteins are the proteins left in 
the milk when caseins are removed by acidification. Caseins primarily exist in milk in the 
form of micelles, which are structures formed with different major casein proteins 
stabilized by kappa-casein and organic and inorganic ions, such as calcium (Jenness, 
1974; Lonnerdal, 1985). Composition of these casein micelles and the whey protein 
portion of milk vary among species. The only major casein in human milk is beta-casein, 
which is almost entirely bound in micelles (Lonnderdal, 1985). The major casein in 
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bovine milk is αs1-casein, though it also contains a large amount of beta-casein and 
smaller amounts of αs2- and gamma-casein. Fewer of the caseins in cow milk are bound 
in micelles than in human milk (Jensen, 1995). Mouse milk contains large amounts of 
both αs1- and beta- casein with smaller amounts of gamma-casein (Boumahrou et al., 
2009). All three contain smaller amounts of kappa-casein, which helps the others form 
micelles in the milk. The whey portion of milk consists of different proportions of α-
lactalbumin, lactoferrin, beta-lactoglobulin, immunoglobulins, serum albumin, whey 
acidic protein, enzymes, hormones and growth factors. Beta-lactoglobulin is primarily 
found in cow milk, while whey acidic protein is primarily found in mouse milk. 
Immunoglobulin and serum albumin are not made in the MEC, but transported from the 
blood into the milk by these cells instead (Boumahrou et al., 2009; Kinsella and 
Whitehead, 1989; Lonnderdal, 1985).  
In addition to the secreted milk proteins, the cell is generating the proteins involved in 
their production and the production of other milk components and cell maintenance 
requirements. To support the high protein synthesis and processing demand, MEC 
prepare for lactation by synthesizing more Golgi and rough endoplasmic reticulum 
(Hollman, 1974), which can then aid in the production of the necessary proteins for milk 
production. Among these proteins being produced are receptors for hormones and growth 
factors secreted by other cells as well as components of cell signaling initiated by 
activation of the receptors that cue the cell to produce the proteins needed for the jobs it 
has to perform. Milk protein production as well as transport of immunoglobulin is largely 
regulated by PRL and phosphorylation of PRLR’s downstream transcription factor, 
STAT5. As previously mentioned, expression of enzymes involved in lactose synthesis 
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and glycolytic and lipogenic pathways are also regulated by this hormone (Anderson et 
al., 2007).  Seen by the diverse roles of proteins in the MEC, the proper regulation of 
protein synthesis is important for every aspect of milk production and secretion. 
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1.2.2.6 Involution 
After completion of functional development and the duration of lactation, the offspring 
no longer require milk for nourishment and the gland undergoes involution, returning to a 
near virgin state. This process has been most studied in mice and the following 
information will stem from studies done in this species. Involution naturally occurs 
gradually as offspring slowly shift to other food sources, though most studies investigate 
the effects of abrupt weaning during mid-lactation in order to investigate the initiation of 
different events occurring during involution (Richert et al., 2000). Consequently, timing 
mentioned here is based off of abrupt weaning and involution while these events most 
likely occur naturally in a similar manner but spread over the time of weaning.  
Involution is a two-step process characterized by an early and reversible phase of MEC 
apoptosis and shedding, followed by an irreversible stage of ECM and gland remodeling. 
The initiation of involution is caused by milk stasis in the alveolar lumen and can be 
reversed by suckling until remodeling has begun. In mice, the first stage of reversibility 
lasts approximately 48 hours (Watson, 2006). When milk builds up in the lumen of the 
alveoli, the MEC appear flattened due to the pressure of the building milk volume in the 
extended alveoli (Richert et al., 2000) and this milk stasis induces expression of many 
different factors implicated in the apoptotic pathways of involution. Milk accumulation 
induces the expression of leukemia inhibitory factor (Lif), which appears in the alveolar 
lumen and activates Lif-receptor (LifR) on the MEC luminal membrane. This 
subsequently activates the Jak/STAT pathway, leading to the phosphorylation and 
activation of STAT3. While STAT5 is important in development of the functional 
mammary gland, STAT3 is essential in its involution after lactation (Watson et al., 2006; 
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Stein et al., 2007). STAT3 induces expression of several important players in the onset of 
involution such as C/EBPδ, IGFBP5 and regulatory subunits of PI3-kinase which are 
involved in the anti-inflammatory pathway and inhibition of Akt activation, which would 
otherwise aid in cell survival (Stein et al., 2007). Vitamin D receptor and the TNF/death 
receptor pathway take a more direct approach. While they inhibit Akt, they also induce 
caspase activity, which directly leads to apoptosis. At this stage of involution caspase 
acitivty is only seen in cells shed into the lumen (Stein et al., 2007; Watson et al., 2006).  
During the beginning phase of involution the only difference apparent in the gland is the 
increased shedding of MEC, but the irreversible second stage is characterized by major 
remodeling of the epithelium and stroma. Alveolar structures begin to collapse due to 
detachment from the ECM and caspase activity is now seen in MEC still attached to the 
luminal wall. Matrix metalloproteases (MMPs) are essential to this second stage of tissue 
remodeling. They are responsible for the remodeling of the ECM and detachment from 
the MEC layer. They also cleave plasminogen to plasmin, which is required for normal 
stromal remodeling and adipocyte repopulation (Watson, 2006). When the alveoli 
collapse, adipocytes begin accumulating lipid and filling in the open space of the stroma. 
Infiltrating immune cells and surviving MEC perform clearance of dead cells and debris. 
Resident MEC engulf milk fat globules, casein micelles, and apoptotic MEC and have the 
ability to release the same key cytokines in response as the professional phagocytes. The 
professional phagocytes also play a role in the clean up; macrophages and neutrophils 
engulf milk components and phagocytize apoptotic cells (Atabai et al., 2007; Watson et 
al., 2006). The rearranging and clearance continues until the gland has returned to a 
mature, quiescent state that nearly mimics an adult virgin gland, which in mice is 
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approximately 10-15 days post weaning (Richert et al, 2000; Lund et al., 1996; Lascelles 
and Lee, 1978). 
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1.2.2.7 Quiescence 
After involution is complete, the mammary gland enters a period of quiescence until 
pregnancy initiates another surge in growth and development. Although the post-
involution gland appears very similar to the mature virgin gland, there are persisting 
differences. First, the morphological appearance of the gland varies slightly from the 
virgin state. In humans and mice the complexity of the glandular tissue in the parous 
gland is higher than in the nulliparous gland (Richert et al, 2000; Daniel and Silberstein, 
1987). In addition to slight morphological differences, persisting molecular differences 
exist. In a study by D’Cruz and colleagues (2002) the lasting effects of parity on 
mammary gland gene expression was analyzed by microarray. Among the genes that 
were down-regulated with parity were growth factors such as amphiregulin and IGF-1, 
which promote cell growth and survival. Among the much longer list of up-regulated 
genes were transcripts indicating a higher state of differentiation, such as all major milk 
proteins, as well as immunoglobulin and factors involved in TGF-β signaling. These 
differentially expressed transcripts indicate a higher order of differentiation as well as 
more of a presence of immune cells and increased incidence of growth inhibition. If the 
proteins of these transcripts are also expressed, this may help explain the well-
documented protection of parity from breast cancer (MacMahon et al., 1970; Britt et al., 
2007). 
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1.2.3 Breast cancer incidence 
Effect of parity on breast cancer risk has been recognized and documented since the early 
1900s (Lane-Claypon, 1926; Wainwright, 1931). Both reduced and increased risks are 
associated with different parity conditions. A transient increase in the risk of breast 
cancer immediately following a pregnancy has been documented, which is also decreased 
with increasing parity (Lambe et al., 1994). Risk of breast cancer development was found 
to be reduced by 10% with each additional full term pregnancy (Lambe et al., 1996). Age 
of first parity also has a large influence on risk. Women who are older than thirty at their 
first full term pregnancy have a higher risk of developing breast cancer than nulliparous 
women (Kelsey et al., 1993). While late age of first parity has a detrimental effect, early 
age at first parity decreases risk of breast cancer development. The reduced risk of breast 
cancer due to early age at first full term pregnancy became well known when MacMahon 
and colleages performed a study in 7 different areas around the world and recognized and 
stressed the importance of this factor (1970). Since then, studies in rodents and humans 
have confirmed this protective factor of early pregnancy and have found that steroid 
receptor positive breast cancer risk is decreased by early childbirth (Britt et al., 2007; Ma 
et al., 2006). Several studies have focused on identification of the molecular factors 
responsible for this phenomenon (D’Cruz et al., 2002; Ginger et al., 2001; Balogh et al., 
2006), and some potential molecules and processes have been discovered, but too few 
reports and too many potential factors make concrete conclusions impossible. The studies 
mentioned also all looked at persisting transcripts, while persisting protein expression 
might provide a more focused list of potential future investigations. Continued 
	  38 
 
comparisons between the different states of the gland offer increased potential of 
unveiling persisting factors that might influence this difference seen in breast cancer risk.  
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1.3 Bioinformatics 
The expanding field of bioinformatics and the increasing importance for interdisciplinary 
studies has been well documented and is only growing more apparent (Wolkenhauer and 
Hofmeyr, 2013; NRC, 2010; Howe et al., 2008). Few experimentation techniques in 
biological research remain that do not utilize computer software for some aspect of the 
study and computers are necessary for storing, organizing and performing the analysis of 
data. With the emergence of systems biology and “–omic” technologies, computer 
analysis and data sharing has become fundamental to all progress. While individual fields 
of study are becoming narrower in their focus and splitting into more divisions, these 
divisions are becoming more difficult to assign under a larger category; that is, the lines 
between fields of study are becoming blurred. It is becoming more important to have a 
larger variety of knowledge in order to understand the details of these smaller topics. To 
go along with these trends, individualized computer programming is being generated to 
fit the needs of the specific fields of study. At the 2013 Plant and Animal Genome 
conference in San Diego, an unofficial survey revealed that approximately 55 abstracts 
were presented detailing computer programs designed to aid in -omic data management. 
Among them, topics addressed included genome annotation, genotype and phenotype 
association, transcriptome assessment, and regulation of gene expression. With the 
narrowing focus of study topics and the growing amount of data that can be generated, 
this observation did not come as a surprise.  
Need for this cross-discipline has been recognized and attempts are being made to 
advance its progress. Classes introducing undergraduates to bioinformatics tools have 
appeared in many universities. Barbara May reported on the success of a class aimed at 
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this goal. Students learned to analyze genomes and annotate genes, giving mostly positive 
feedback (May, 2013). May is the far from the first to begin these types of studies; in 
fact, it is now very common to even find degrees available involving bioinformatics in 
universities. A survey was originally compiled in 2002 for a meeting of the American 
Society of Information Science and Technology that included a list of universities that 
offered bioinformatics related programs and degrees, and is continuously updated by 
Bradley Hemminger at the School of Information and Library Services at the University 
of North Carolina at Chapel Hill. In 2002 the list from the survey included 27 different 
programs and by 2012 the list had increased to 87 different programs; that is 60 new 
programs in ten years (SILS, 2013). The programs offer degrees related to bioinformatics 
ranging from certificate programs and minors to BS, MS and PhD degrees. The degree 
programs are based in departments ranging from biology to computer science to 
mathematics departments. Some universities have their own department dedicated to 
bioinformatics, and some are interdepartmental or interinstitutional programs. 
Huge progress has been made in the recent years toward interdisciplinary studies, but 
many of the programs are still new and continued advancement and improvement of 
these programs is necessary for the advancement of the biological studies as the data sets 
being produced are overwhelming without the help of advancing technology. 
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1.4 Summary 
Development of the mammary gland through the life of the female mammal is under the 
influence of hormonal and intracellular signals, many of which are yet to be discovered. 
These signals allow for the differentiation of the MECs into entities able to produce and 
secrete the components of milk. In addition to the differentiation into milk producing 
phenotypes, the cells also regress to a quiescent state during times of non-pregnancy. 
Understanding of the events behind these developmental stages is of interest to several 
different populations because of the potential influence on dairy production, breast 
feeding, and breast cancer research. 
Investigation into the development of the mammary gland is often performed by utilizing 
large scale investigative methods such as microarray and proteomics. This type of 
analysis can be made easier with the help of computer applications and collaboration with 
technological fields. Specific computer software for a lab’s individual purposes can 
relieve many of the difficulties that come with analyzing large data sets. Emerging 
interdisciplinary study programs that allow students to learn the technological side and 
biological side of this type of research will be of much value to future generations of 
scientists. 
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CHAPTER 2 – Proteomic Analysis of HC11 Differentiation 
2.1 Introduction 
The role of the differentiated mammary epithelial cell (MEC) during lactation is to 
produce and transport all of the essential nutrients for the organism’s offspring including 
lactose, fatty acids and triacylglycerol, amino acids and proteins, vitamins, minerals, and 
several other important components needed for the growing infant (Mepham, 1983). The 
nutrients available to the MEC, metabolic capabilities of the organism, and nutritional 
needs of the young determine the components used and secreted in the milk. Because of 
these determining factors some differences in molecular processing and the metabolic 
pathways leading to the end products found in milk would be expected among species 
and individuals, but despite the differences expected, the overall story should remain 
similar due to the responsibility of the functional mammary gland across all mammals. 
Mammary differentiation is studied through in vitro cell culture experiments, tissue 
explants, and whole tissue samples (Desrivieres et al., 2003; Collier et al., 1977; D’Cruz 
et al., 2002). Each method of study has advantages and disadvantages. Cell culture allows 
for study of individual cell types, but removes the natural environment of the cells and 
cell lines can misrepresent their primary cell counterparts. Explants and whole tissue 
samples may provide more of a natural environment for the study of the gland, but 
information is obtained for the gland as a whole, and information on individual cell types 
is lost. A recent investigation in the Peterson lab was done using isolated primary MEC 
from pregnant and lactating mice, which allows development in the natural environment 
and the investigation of an individual cell type (Strand, 2012). Comparison of this data to 
that of the HC11 cell line differentiated in culture would provide valuable information. 
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This experiment analyzes the differing protein profiles between the undifferentiated and 
differentiated states of the murine HC11 MEC line and compares this analysis with 
different models of MEC differentiation. While the process of differentiation cannot be 
fully understood with a just snapshot of the proteome on either side of the main event, 
this analysis distinguishes aspects of MEC differentiation for which cell lines may or may 
not be appropriate models and indicates the importance of comparative analysis among 
species and models to reveal commonalities, which will be important for future attempts 
at identifying central regulatory networks of MEC development.    
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2.2 Methods 
2.2.1 Cell culture 
HC11 murine mammary epithelial cells (Ball et al., 1988) were grown to confluence in 
RPMI 1640 media supplemented with 10% fetal bovine serum (FBS; Innovative 
Research, Novi, MI), 1% penicillin/streptomycin (PS), 1% amphotericin B, 5 μg/ml 
insulin, and 10 ng/ml epidermal growth factor (EGF). Half of the cells (n=3) were taken 
for protein extraction at the point of confluence. Differentiation was then induced in the 
remaining cells by incubating with EGF-free growth media for 48 hours followed by 4 
days incubation in RPMI 1640 with 10% FBS, 1% PS, 1% amphotericin B, 5 μg/ml 
insulin, 1μM dexamethasone, and 1μg/ml prolactin. The remaining cells (n=3) were used 
for protein extraction after day 4 when domes were present in the cells, indicating a 
differentiated state. 
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2.2.2 Protein extraction 
Three plates of cells were pooled for each protein extraction sample leading to 3 samples 
per treatment (n=3). Media was aspirated from plates and cells were transferred to 
microcentrifuge tubes and rinsed with PBS. Cells were then lysed by sonication in 
homogenization buffer (7 M urea, 2 M thiourea, 40 mM tris base, 1% ASB-14, 40 mM 
DTT, 0.5% ampholyte IPG, 0.001% bromophenol blue). Lysate was separated by 
centrifugation for 30 minutes at 10,400 x g and 4°C and supernatant containing isolated 
soluble proteins was transferred to a new tube. 
Protein was precipitated with 10% trichloroacetic acid in acetone overnight at -20°C. 
Protein was rinsed with 100% acetone and allowed to dry. Protein was solubilized 
overnight at 4°C in rehydration buffer containing 7 M urea, 2 M thiourea, 2% CHAPS, 
2% nonidet P-40, 100 mM DTE, 0.5% ampholyte IPG, and 0.002% bromophenol blue. 
After centrifugation for 15 min at max speed and 4°C, supernatant containing solubilized 
protein was transferred to a clean tube and stored at -80°C. 
Protein was quantified using the 2-D Quant Kit (GE Healthcare Life Sciences, Pittsburgh, 
PA). 
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2.2.3 Two-dimensional gel electrophoresis (2DGE) 
All equipment and materials used for 2DGE were purchased from Bio-Rad (Hercules, 
CA) unless otherwise stated. All buffer reagents were purchased from Sigma-Aldrich (St. 
Louis, MO) unless otherwise stated. 
Immobilized pH gradient strips (11 cm, pH 3 -10) were actively rehydrated with the 
rehydration buffer containing the protein samples for 12 hours at 50 V. Isoelectric 
focusing (IEF) for the first dimension of separation was then performed at ~8,000 V and 
20°C for 35,000 Volt hours. Active rehydration and IEF were performed using the 
Protean IEF Cell. Strips were stored at -80°C until subjected to the second dimension. 
For the second dimension, IPG strips containing protein were incubated with 
equilibration buffer (375 mM tris-HCl (pH 8.8), 6 M urea, 30% glycerol, 2% SDS, 
0.002% bromophenol blue) containing 10 mg/ml DTT on a rotator for 15 min at room 
temperature followed by incubation with equilibration buffer containing 25 mg/ml 
iodoacetamide for 15 min. Proteins were then separated by molecular mass using 11 cm 
10% polyacrylamide Criterion tris-HCl gels using the Criterion Dodeca Cell at 200 V, 
allowing all gels to be run simultaneously. Samples were run in duplicate and proteins in 
all gels were stained overnight with colloidal Coomassie Blue G-250 and de-stained with 
Type I DI water. 
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2.2.4 Gel analysis, spot picking and trypsin digestion 
Stained gels were scanned using an Epson 1280 transparency scanner (Epson, Long 
Beach, CA, USA). Scanned gel images were processed and analyzed by Delta 2D 
(version 3.6, Decodon, Greifswald, Germany). Spots boundaries were defined and gels 
were overlaid and fitted to align corresponding spots across gels. Differentially expressed 
protein spots were identified using a t-test performed according to a null distribution that 
was generated with 1000 permutations in order to account for unequal variance and non-
normal distribution of data. 
Protein spots that differed in abundance due to treatment were excised using a manual 1.5 
mm tissue puncher (Beecher Instruments, Prairie, WI) and stored at -80°C in 0.5 ml 
microcentrifuge tubes until further processing. Gel plugs containing individual protein 
spots were destained twice by incubation for 30 min at room temperature on a shaker 
with destaining buffer (25 mM ammonium bicarbonate in 50% acetonitrile), dehydrated 
with 100% acetonitrile, and digested overnight with trypsin solution (11 μg/μl MS-grade 
porcine trypsin gold (Promega, Madison, WI) in 40mM ammonium bicarbonate/10% 
acetonitrile) at 37°C. Digested proteins were eluted with analyte solution (0.1% 
trifluoroacetic acid (TFA)/acetonitrile 2:1) for 30 min on a shaker at room temperature, 
repeated twice. Samples were concentrated using a SpeedVac (Thermo Fisher Scientific, 
Waltham, MA) at 45°C, resuspended in 6 μl of matrix solution (0.2 mg/ml α-cyano-4-
hydroxycinnamic acid in acetonitrile) and plated on an Anchorchip target plate (Bruker 
Daltonics Inc., Billerica, MA). Plated protein spots were washed with 0.1% TFA and 
recrystallized with acetone/ethanol/0.1% TFA (6:3:1). 
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2.2.5 Mass spectrometry and protein identification 
Peptide mass fingerprints (PMFs) were obtained using a matrix-assisted laser desorption 
ionization tandem time-of-flight (MALDI TOF/TOF) mass spectrometer (Ultraflex II; 
Bruker Daltonics Inc., Billerica, MA). Trypsin was used for internal mass calibration. 
PMFs were analyzed using MASCOT server launched from BioTools software (Bruker 
Daltonics, Billerica, MA) against the NCBI database. PMF were further analyzed using 
MS/MS spectra using five to ten of the largest peaks per sample (excluding keratin and 
trypsin). Spectra were internally calibrated and processed using FlexAnalysis software 
(Bruker Daltonics, Billerica, MA). PMF and MS/MS spectra were combined and queried 
as described for PMF spectra analysis using the MS/MS spectra.  
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2.3 Results 
All gels containing both undifferentiated and differentiated HC11 cell protein extracts 
were scanned and overlaid, creating one fused image for use in spot detection. Delta2D 
analysis of the fused gel image detected a total of 337 individual protein spots (Figure 1). 
Of the detected spots, 98 of these spots differed in abundance between the two treatments 
(P < 0.02), and 90 of these differentially expressed spots were identified when using the 
MASCOT server and matching the spectra to the NCBI Database (Table 1). Of the 90 
identified spots, 41 were up regulated and 49 were down regulated in the differentiated 
HC11 cells when compared to the undifferentiated cells.  
Functional groups for the majority of the identified differentially expressed proteins 
include energy metabolism (24 spots total; 18 up regulated/6 down regulated), 
cytoskeletal dynamics (16 spots total; 6 up regulated/10 down regulated), transcriptional 
regulation and RNA processing (11 spots total; 8 up regulated/3 down regulated), and 
protein folding and processing (27 spots; 6 up regulated/21 down regulated).  
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Figure 1. Fused gel image of HC11 protein spots. Protein was extracted from 
undifferentiated and differentiated HC11 cells and protein was subjected to 2-
dimensional gel electrophoresis, stained with Coomassie blue, and analyzed by Delta 2D. 
The image represents all gels fused into one image. Labeled spots were differentially 
expressed between treatments (P < 0.02). Numbers correspond to “Spot ID” in Table 1. 
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Figure 2. Heat map of differentially expressed 
HC11 protein spots. Created by hierarchical 
clustering using Pearson’s correlation of HC11 
protein spots that were differentially expressed 
between the undifferentiated and differentiated 
states (P<0.02). Blue represents lower than 
average protein abundance, while orange 
represents higher than average protein 
abundance for that particular spot. Rows 
represent individual spots and the numbers 
correspond to “Spot ID” in Table 1. Columns 
represent individual gels. Differentiated 
treatment gels are on the left and 
undifferentiated treatment gels are on the right.  
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Figure 3. Proposed energy metabolism pathways in differentiated HC11 cells. Green 
represents up regulation and red represents down regulation in differentiated cells (P < 
0.02). The protein expression profile indicated shifts in pathway flux to spare glucose for 
lactose synthesis, support energy generation from amino acids and redirect amino acid 
carbon skeletons, oxaloacetate and acetyl CoA out of the mitochondria for use in 
triacylglycerol synthesis in the cytosol.  
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Table 1. List of identified protein spots that were differentially expressed between 
undifferentiated and differentiated HC11 cells (P < 0.02). Under “Direction of 
Regulation,” “up” indicates an increased abundance of the specified protein, while 
“down” means the decreased abundance of the specified protein in the differentiated cells 
relative to the undifferentiated cells. “Fold change” indicates magnitude of abundance 
change and was calculated by dividing mean spot abundance of differentiated gels by 
mean spot abundance of undifferentiated gels. 
Spot 
ID Protein Name 
Gene 
Name 
Direction 
of 
Regulation 
Fold 
change 
angiogenesis & differentiation 
40 angiopoietin-2 Angpt2 up 1.90 
cell signaling 
21 complement component 1 Q subcomponent-binding 
protein, mitochondrial 
C1qbp down 0.63 
97 guanine nucleotide-binding protein subunit beta-2-like 1 Gnb2l1 down 0.75 
22 high affinity nerve growth factor receptor precursor  Ntrk1 down 0.47 
12 14-3-3 gamma protein Ywhag down 0.69 
10 14-3-3 protein theta Ywhaq down 0.40 
cytoskeleton 
68 beta-actin Actb up 1.21 
54 gelsolin, cytosolic Gsn down 0.24 
2 gelsolin, cytosolic Gsn up 2.67 
9 integrin beta-4, partial Itgb4 down 0.32 
63 keratin, type I cytoskeletal 14 Krt14 down 0.48 
66 keratin, type I cytoskeletal 15 Krt15 up 2.55 
65 keratin, type I cytoskeletal 17 Krt17 down 0.48 
67 keratin, type I cytoskeletal 17 Krt17 down 0.60 
70 keratin, type II cytoskeletal 5 Krt5 down 0.49 
37 keratin, type II cytoskeletal 5 Krt5 down 0.49 
71 keratin, type II cytoskeletal 5 Krt5 down 0.66 
77 keratin, type II cytoskeletal 5 Krt5 down 0.74 
59 keratin, type II cytoskeletal 7 Krt7 down 0.49 
75 prelamin-A/C isoform A Lmna up 1.33 
76 prelamin-A/C isoform A Lmna up 1.34 
60 septin-8, partial Sept8 up 2.45 
DNA replication & cell division 
53 DNA replication licensing factor Mcm7 down 0.64 
17 proliferating cell nuclear antigen Pcna down 0.14 
73 ruvB-like 1 Ruvbl1 down 0.48 
ion transport 
55 mitochondrial inner membrane protein, partial Immt up 1.30 
88 voltage-dependent anion-selective channel protein 2 Vdac2 down 0.27 
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Spot 
ID Protein Name 
Gene 
Name 
Direction 
of 
Regulation 
Fold 
change 
metabolism 
94 long-chain specific acyl-CoA dehydrogenase, 
mitochondrial precursor 
Acadl up 1.53 
81 medium-chain specific acyl-CoA dehydrogenase, 
mitochondrial precursor 
Acadm up 1.86 
38 very-long-chain acyl-CoA dehydrogenase Acadvl up 1.70 
39 aconitate hydratase, mitochondrial precursor Aco2 up 1.45 
74 aldehyde dehydrogenase, mitochondrial precursor Aldh2 up 2.19 
84 arginase-1 Arg1 up 2.10 
30 arginase-1 Arg1 up 2.17 
92 ATP synthase subunit alpha, mitochondrial precursor Atp5a1 down 0.42 
98 electron transfer flavoprotein subunit alpha, mitochondrial Etfa up 2.41 
87 glyceraldehyde-3-phosphate dehydrogenase Gapdh up 1.28 
90 glyceraldehyde-3-phosphate dehydrogenase Gapdh up 1.66 
26 3-hydroxyisobutyrate dehydrogenase, mitochondrial 
precursor 
Hibadh up 2.05 
24 malate dehydrogenase, cytosolic Mdh1 down 0.59 
25 3-mercaptopyruvate sulfurtransferase Mpst up 2.81 
44 C-1-tetrahydrofolate synthase, cytoplasmic Mthfd1 down 0.44 
29 omega-amidase Nit2 down 0.23 
95 succinyl-CoA:3-ketoacid coenzyme A transferase 1, 
mitochondrial precursor 
Oxct1 up 1.36 
43 pyruvate carboxylase, mitochondrial isoform 1 Pc up 1.84 
80 phosphoglycerate kinase 1 Pgk1 up 1.33 
35 pyruvate kinase M Pkm down 0.79 
96 phosphoserine aminotransferase isoform 1 Psat1 down 0.57 
72 succinate dehydrogenase flavoprotein subunit, 
mitochondrial, partial 
Sdha up 1.77 
91 serine hydroxymethyltransferase 2, mitochondrial Shmt2 up 1.45 
34 transketolase Tkt up 1.23 
plasma protein 
78 serum albumin precursor Alb up 1.61 
protein synthesis & processing 
61 t-complex protein 1 subunit beta Cct2 down 0.68 
36 t-complex protein 1 subunit eta Cct7 down 0.53 
7 cathepsin B Ctsb down 0.60 
41 cathepsin D precursor Ctsd up 1.92 
27 cathepsin D precursor Ctsd up 2.21 
79 dnaJ homolog subfamily A member 1 Dnaja1 down 0.51 
19 elongation factor 1-delta Eef1d down 0.46 
46 elongation factor 2 Eef2 down 0.54 
49 elongation factor 2 Eef2 down 0.55 
45 elongation factor 2 Eef2 down 0.57 
47 elongation factor 2 Eef2 down 0.67 
3 glycine - tRNA ligase Gars down 0.44 
23 endoplasmin Hsp90b1 down 0.59 
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Spot 
ID Protein Name 
Gene 
Name 
Direction 
of 
Regulation 
Fold 
change 
31 heat shock protein beta-1 Hspb1 down 0.16 
57 chaperonin Hspd1 down 0.42 
16 nascent polypeptide-associated complex subunit alpha 
isoform b 
Naca down 0.37 
13 nucleophosmin isoform 1 Npm1 down 0.50 
15 nucleophosmin isoform 3 Npm1 down 0.36 
56 protein disulfide-isomerase P4hb up 1.46 
4 protein disulfide-isomerase A4 precursor Pdia4 up 1.54 
50 procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 Plod2 up 1.78 
51 procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 Plod2 up 1.90 
82 peptidyl-prolyl cis-trans isomerase D Ppid down 0.65 
8 proteasome subunit alpha type-2  Psma2 down 0.60 
11 proteasome subunit alpha type-5 Psma5 down 0.40 
18 40S ribosomal protein SA Rpsa down 0.71 
58 t-complex polypeptide 1A Tcp1 down 0.60 
transcriptional regulation & processing 
86 heterogeneous nuclear ribonucleoproteins A2/B1 isoform 
2 
Hnrnpa2b1 up 1.19 
85 heterogeneous nuclear ribonucleoproteins A2/B1 isoform 
2 
Hnrnpa2b1 up 1.74 
83 heterogeneous nuclear ribonucleoprotein A3 isoform c Hnrnpa3 up 1.76 
93 heterogeneous nuclear ribonucleoprotein A/B isoform 2 Hnrnpab down 0.63 
64 heterogeneous nuclear ribonucleoprotein H2 Hnrnph2 up 1.32 
89 max-like protein X isoform gamma Mlx up 2.27 
48 tRNA (cytosine(34)-C(5))-methyltransferase Nsun2 down 0.55 
69 ribonuclease/angiogenesis inhibitor Rnh1 down 0.15 
6 TAR DNA-binding protein 43 isoform 1 Tardbp up 1.58 
42 TAR DNA-binding protein 43 isoform 1 Tardbp up 3.08 
1 tripartite motif protein 28 Trim28 up 2.02 
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2.4 Discussion  
In this study, protein expression of the HC11 murine MEC line was compared between 
its undifferentiated state, used to represent the theoretical state of pregnancy, and its 
differentiated state, used to represent the theoretical state of lactation. Samples were 
taken at the proliferating stage and after being treated with a three-hormone cocktail 
(dexamethasone, insulin, prolactin; DIP), respectively. Treatment with DIP has been 
shown to yield cells with characteristics of a lactating MEC based on expression of beta-
casein and formation of mammospheres (Ball et al., 1988; Blachford et al., 1995; 
Morrison and Cutler, 2009). The method of analysis used in 2DGE allows the discovery 
of many protein changes occurring at a point in time before and after differentiation, but 
it does not provide a complete list of all occurrences leading to the differentiated cell 
type. This analysis allows the proposal of potential events occurring, which can then be 
explored and validated through additional experimentation.  
Changes in the protein profile of these HC11 cells after differentiation are largely in 
agreement with a very similar study performed ten years prior (Desrivieres et al., 2003) 
and appear to indicate shifts appropriate for the switch to a milk producing phenotype. 
Differential expression of identified proteins involved in energy metabolism indicated 
shifts in pathway flux to spare glucose for lactose synthesis, support energy generation 
from amino acids, and redirect amino acid carbon skeletons, oxaloacetate and acetyl CoA 
out of the mitochondria for use in triacylglycerol synthesis in the cytosol. Shifts in 
cytoskeletal proteins indicated a change to a polarized and stable phenotype and to 
support vesicular transport and transcriptional activity of the cell. Increased abundance of 
many transcriptional regulators and RNA processing proteins suggested an increased 
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output of transcripts, while the majority of changes involving protein processing implied 
the opposite – decreased protein biosynthesis and processing.  
 
2.4.1 Metabolism 
Changes in abundance of energy metabolism enzymes and proposed metabolic pathways 
in use in the differentiated state of the HC11 cells are shown in Figure 3 and should be 
referenced as the discussion proceeds. All differentially expressed proteins mentioned are 
also listed in Table 1 of the results section. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and phosphoglycerate kinase 
(PGK1) are both increased in differentiated cells, appearing to support the possible 
increase in the process of glycolysis as their reactions reversibly convert glyceraldehyde 
3-phosphate to 1,3-bisphosphoglycerate, and 1,3-bisphosphoglycerate to 3-
phosphoglycerate, respectively. The increase of pyruvate kinase (PKM) seen previously 
in multiple studies would substantiate the idea of increased glycolysis leading to high 
levels of pyruvate to be used for ATP production, all driven by a high glucose supply 
(Desrivieres et al., 2003; Rudolph et al., 2007; Strand, 2012). In this particular study, 
however, PKM was actually decreased in differentiated cells, leading to an alternative 
explanation of glucose sparing and energy production through other means. Down 
regulation of PKM would lead to a buildup of its substrate, phosphoenolpyruvate (PEP), 
as well as a decreased production of pyruvate from PEP. Phosphoglycerate kinase and 
GAPDH were both increased in the differentiated cells, but these enzymes can catalyze 
the conversion of their substrates and products reversibly. The accumulation of PEP, 
down regulation of PKM and increase of PGK1 and GAPDH would drive the direction of 
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glycolytic enzyme activity to move toward the product glyceraldehyde 3-phosphate 
(G3P).  This pool of G3P could then serve several purposes. Some G3P could be 
converted to dihydroxyacetone phosphate (DHAP) and be used for triacylglycerol  
(TAG) synthesis.  A portion of G3P could also be converted to glucose 6-phosphate 
(G6P) and shuttled into the pentose phosphate shunt (PPS) in order to produce the 
NADPH needed for fatty acid synthesis – a possibility supported by the up regulation of 
the PPS enzyme transketolase (TKT) in the differentiated state. This conversion to G6P 
would also allow more of the glucose in the cell to be directed toward lactose synthesis, 
which is in agreement with the previous findings that glucose phosphate isomerase has 
been shown to decrease in transcript abundance at onset of lactation, which would 
decrease the entrance of G6P into glycolysis (Rudolph et al., 2007). 
If the enzyme abundance indicates the use of glucose for lactose synthesis and reverse 
glycolytic substrate conversion so as to shuttle substrates away from entering the TCA 
cycle, it is important to consider source of energy production and level of energy 
utilization in the MEC. Though the enzymes mentioned above have changed in 
abundance from the pregnant to the lactating state of the MEC, they are not nonexistent 
in one state or the other. A small amount of glucose is still being used for energy and a 
portion is still being transported into the PPS. Also, the energy production seems to be 
reduced from the proliferative pregnant state of the cell, which very well may require a 
higher level of ATP output relative to the differentiated lactating-like state. This idea is 
supported by the decrease in ATP synthase subunit alpha (ATP5A1), which is part of the 
F1, catalytic portion of the ATP synthase enzyme and required for the production of ATP 
in the respiratory chain (Wang and Oster, 1998).  
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In addition to requiring less energy in total, the differentiated cell appears to use more 
amino acids for energy and nutrient production. Serine hydroxymethyltransferase 2 
(SHMT2) is increased in abundance and catalyzes the production of serine from glycine 
in the mitochondria, which can then be converted to 2-phosphoglycerate and transported 
into the cytosol where it can enter the glycolytic pathway to be used for production of 
energy or milk components. While production of pyruvate through means of glycolysis 
may be decreased due to down regulated PKM, it can also be made from threonine in a 
series of three conversions of which the last is catalyzed by aldehyde dehydrogenase 
(ALDH2); ALDH2 is increased in differentiated HC11 cells. Several acyl CoA 
dehydrogenases (ACAD) were also up regulated. These enzymes could be a part of fatty 
acid remodeling, or could serve to produce acetyl CoA from lysine in the mitochondria. 
Lysine is converted to α-ketoadipate in the cytosol and transported into the mitochondria, 
changed into glutaryl CoA and acted upon by ACAD, eventually leading to the 
production of acetyl CoA (Salway, 1994). This provides a pool of acetyl CoA in the 
mitochondria that is produced from a source other than pyruvate.  Arginase (ARG1) 
abundance has repeatedly been shown to increase in the lactating mammary gland, 
including in this experiment (Yip and Knox, 1972; Oka and Perry, 1974; Mezl and Knox, 
1977). The absence of other enzymes involved in the urea cycle has indicated an alternate 
role in the production of proline and glutamate from arginine. Other enzymes in these 
pathways have also been shown to increase in the lactating mammary gland and are 
thought to be necessary for production of milk proteins (Yip and Knox, 1972; Mezl and 
Knox, 1977). 
Complementing the increased use of amino acids for energy and decreased overall need 
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for ATP, increased abundance of pyruvate carboxylase (PC), which converts pyruvate 
into oxaloacetate, and of aconitase (ACO2), which catalyzes the bidirectional conversion 
of citrate and isocitrate, supports increased production of citrate from oxaloacetate and 
acetyl CoA. In the rodent mammary gland, the citrate can be shuttled out of the 
mitochondria and the enzyme citrate lyase would catalyze the splitting of citrate back into 
oxaloacetate and acetyl CoA in the cytosol. This shuttling of citrate out of the 
mitochondria to allow acetyl CoA escape from the mitochondria for use in fatty acid 
synthesis has been documented, but is usually in concert with conversion of oxaloacetate 
into malate by cytosolic malate dehydrogenase (MDH1), and then into pyruvate for 
reentrance into the TCA cycle as part of the pyruvate/malate cycle, which is a means of 
NADPH production (Anderson et al., 2007; Rudolph et al., 2007). In this study MDH1 
was down regulated, so the excess oxaloacetate produced must be directed in an 
additional, or different direction. Instead, the oxaloacetate could be converted into PEP 
by PEPCK in the cytosol and contribute to the reverse activity of glycolytic enzymes and 
continued increase of TAG synthesis, the PPS, and glucose sparing for lactose 
production. 
Energy metabolism changes found in the transformation of HC11 cells from the 
undifferentiated to differentiated state largely support current knowledge of rodent 
mammary metabolism with just two enzyme regulation changes that seem to differ from 
previous findings, but may bring into question aspects of metabolic pathway flux. The 
decreased abundance of PKM and MDH1 in the differentiated state has not previously 
been detected and indicates a redirection of substrates in the glycolytic pathway and use 
of alternate materials for pyruvate production. This discovery may be due to differing 
	  61 
 
nutrient availability or differences in this HC11 cell line with other models and warrants 
further investigation.  
 
2.4.2 Cytoskeleton 
Changes in the profile of cytoskeletal proteins suggested increased stability of the cell 
and active vesicular trafficking as well as decreased need for filaments required for cell 
motility. Most of the keratins found, which included 5, 7, 14 and 17, were down regulated 
while the only up regulated keratin was 15. This was an interesting find that seems to be 
in agreement with some literature because keratin 15 (KRT15) has been found down 
regulated in proliferating cells and up regulated in differentiated, stable cells, while others 
such as keratins 5 and 14 specifically are associated with mitotically active cells and are 
down regulated in differentiated and phenotypically stable cell types (Porter et al., 2000; 
Waseem et al., 1999). Interestingly, although this has been found in certain studies in 
keratinocytes, a study on human mammary gland proposes KRT15 as a marker for a 
luminal progenitor cells and found it to be absent in differentiated lactating cells but 
present in undifferentiated cells (Moriera et al., 2010). This is an important difference to 
investigate and may be based on difference in species or cell source. 
Prelamin-A (LMNA) was up regulated in the differentiated mammary epithelial cell. This 
protein can be in several forms as a precursor to mature lamin A and this precursor has 
been found to be responsible for several roles such as localization of other proteins to the 
nucleus and regulation of transcription due to transcription factor sequestration. It has 
been found to interact in this way with SREBP1, which is known to play a role in 
regulating lipid metabolism (Lattanzi, 2011). 
	  62 
 
Integrin beta-4 (ITGB4) serves with integrin alpha-6 as a receptor for laminins on the 
basement membrane and is thought to exist primarily on basal cells and to not be present 
on most luminal cells (Yang et al., 2009). In this study ITGB4 was down regulated in 
differentiated HC11 cells, which is interesting because the line arose from a luminal 
mammary epithelial cell and is seen in this study not only to express it, but also to change 
its expression with hormone treatment directing a differentiation-like process. 
Gelsolin (GSN) was found to be both up and down regulated, meaning the predominating 
post-translational modified form of GSN was changed. Gelsolin is primarily known for 
its actin regulatory actions due to its ability to both sever and cap actin filaments to aid in 
cell mobility, but it also has a role in the progression of apoptosis. It has been shown to 
inhibit the release of cytochrome c from mitochondria, disallowing caspase-3 activation 
and inhibiting early stages of apoptotic signaling, therefore stabilizing the cell (Koya et 
al., 2000). Perhaps the up regulation of this form of GSN is occurring and allowing the 
differentiated cell to remain stable until involution. If the up regulated form of GSN is 
due to actin remodeling roles, perhaps the rearrangement of actin filaments is necessary 
to allow for vesicular trafficking and transport of milk components out of the cell. This is 
supported by the congruent up regulation of beta-actin and septin 8 in the differentiated 
HC11 cells. Septin 8 has been associated with vesicular trafficking and exocytosis in 
neural cells and is involved in secretory processes in the prostate, testis and ovary (Blaser 
et al., 2003; Ito et al., 2009; Shiryaev et al., 2012); septin 8 is possibly playing the same 
role in the mammary epithelial cell, aiding in transport and exocytosis of milk 
components.  
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2.4.3 Protein biosynthesis and processing 
Of the twenty-two differentially expressed proteins involved in the biosynthesis and post-
translational processing of protein, only four were up regulated in the differentiated cells. 
The majority of proteins was down regulated and involved the management of tRNAs, 
ribosome synthesis, and chaperoning other proteins. Of the four up regulated proteins, 
two of them were protein disulfide-isomerases (P4HB and PDIA4), which help rearrange 
disulfide bonds. This finding is interesting because the major whey protein in mouse milk 
is whey acidic protein (WAP). This protein is cysteine-rich and contains two separate 
domains, joined by disulfide bonds (Hennighausen and Sippel, 1982; Neville and Daniel, 
1987). This increase could indicate a shift in protein product priority. The others were 
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) and cathepsin D (CTSD) 
which form sites for carbohydrate attachment for collagen crosslink stability and break 
down proteins, respectively (Mercer et al., 2003; Benes et al., 2008). This mass down 
regulation of protein processing capability may be due to either a decreased overall 
amount of protein being produced in the differentiated state relative to the 
undifferentiated state, or a large, but more directed production of fewer specific proteins 
to be used in the production and secretion of milk components. 
 
2.4.4 Transcriptional regulation and RNA processing 
Transcript production and processing appeared to be increased immensely. There were a 
total of 9 proteins found to change in abundance; 3 proteins were down regulated and 6 
proteins were up regulated. The up regulated proteins were mostly involved in processes 
indicative of a higher number of transcripts being present in the cell. Four different 
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proteins in the heterogeneous nuclear ribonucleoprotein (HNRNP) family were found to 
differ in abundance; A3, A2B1 and H2 were up regulated and AB was down regulated. 
HNRNPA2B1 and HNRNPH2 are involved in pre-mRNA processing (Dreyfuss et al., 
2002; He and Smith, 2009) and A3 is involved in the cytoplasmic trafficking of RNA and 
mRNA maturation (Ma et al., 2002; Papadopoulou et al., 2012). The down regulated 
HNRNPAB acts as a repressor of transcription (Kamada and Miwa, 1992). TAR DNA-
binding protein 43 (TARDBP) is up regulated and has been shown to interact with 
several hnRNP members and to assist in mRNA processing and stability (Buratte and 
Buralle, 2008). Max-like protein X (MLX) was also increased in abundance and is known 
to interact with another protein, MondoA. This heterodimer has been implicated in the 
transcriptional regulation of many metabolic genes, specifically glycolytic enzymes (Sans 
et al., 2006). 
 
2.4.5 Comparison to Previous Studies 
The changes in functional groups in HC11 seen in this study were largely in agreement 
with a much earlier study performed in the same cell line. Desrivieres and colleagues 
made the same comparison in 2003 using the HC11 cell line and even given the methods 
and time difference, a similar story was told. Protein folding and stability proteins were 
mostly down regulated while RNA processing and metabolic proteins were both largely 
up regulated in the differentiated HC11 cells. Cytoskeletal proteins were split in their 
regulation with many keratins being down regulated. There were many proteins identified 
in each experiment that were not identified in the other, but the general picture that each 
tells appears to agree and the majority of the proteins that were identified in both studies 
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shared direction of regulation. The level of similarity allowed confidence in the 
repeatability of 2DGE experiments and the integrity of the line, but there were a couple 
differences worth mentioning. The first small difference was that PDI was down 
regulated in Desrivieres’ differentiated HC11 cells whereas it was up regulated in the 
present study. This does not have many clear implications, but was a specific difference 
in the two studies. In the Desrivieres study, PKM was up regulated in differentiated cells 
whereas it was down regulated in the present HC11 study. As previously mentioned, this 
is an interesting difference because its level of abundance potentially changes the flow of 
substrates through glycolysis and the direction of energy metabolism. This difference in 
regulation between these two studies of HC11 differentiation indicates that this regulation 
change does not likely reflect the cell source and most likely differs due to environment.  
Proteome changes in HC11 MEC were very different in all major functional categories 
from those observed during differentiation in the MAC-T bovine MEC line (Strand, 
2012). MAC-T showed opposite regulation of several specific protein processing and 
cytoskeletal proteins. Very few proteins involving RNA processing were even identified 
in the MAC-T cells so a proper comparison could not be made. Metabolic proteins 
differed quite a bit, but seemed to accurately demonstrate differences in the metabolic 
enzyme profiles of bovine and murine species. MAC-T cells indicated forward glycolytic 
enzyme activity, build-up of isocitrate and increased PPS activity. Data from a primary 
bovine comparison would be an important contribution to the comparison in order to 
accurately distinguish cell line and specie nuances.  
HC11 cells and primary MEC isolated from pregnant and lactating mice (Strand, 2012) 
exhibited similar changes in proteins involved in metabolism and protein synthesis and 
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folding, but opposite regulation of RNA processing and cytoskeletal proteins. Both the 
primary cells and cell line displayed increases in glycolytic enzymes and citrate 
production due to up regulation of ACO2.  Though not identified in the cell line, citrate 
lyase was found to be up regulated in the primary cells, supporting the idea of citrate 
shuttling out of the mitochondria and splitting into oxaloacetate and acetyl CoA for use in 
fatty acid and TAG synthesis, as previously proposed. 
Interestingly, TKT was down regulated in the primary cells vs. the up regulation of TKT 
in the cell line, perhaps because the primary cells were obtaining some fatty acids from 
the adipocytes and the FA production rate was not as high as in the cell line, requiring 
less NADPH. Pyruvate dehydrogenase was up regulated and PKM was not identified in 
the primary cells, suggesting a possible flow of substrates down the glycolytic pathway 
and into the mitochondria and TCA cycle. Respiratory chain energy production also 
seemed to be increased due to the increase in ATP5A1 in primary lactating cells. Though 
the regulation of many enzymes involved in energy metabolism are left unknown through 
proteomics and absence of their finding does not mean they did not change, speculations 
can be made based on findings that did occur. Regulation of enzymes found in the 
primary cells seem to suggest a possible increased use of glucose for glycolysis and 
energy production relative to the cell line. This possible difference in metabolism could 
be explained in several ways. Signals from adjacent cells or even hormone signals that 
were present in the mammary gland of the mice before MEC isolation could have 
influenced regulation of different metabolic enzymes in the primary cells. The primary 
cells could have also been provided higher levels glucose prior to isolation through diet, 
glycogenolysis and/or gluconeogenesis in the liver of the mouse and this excess glucose 
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was then available for use in lactose synthesis, energy production, and other milk 
component production. 
Speculation about the difference in the cytoskeletal regulation and transcriptional 
regulation is more difficult. More specific cytoskeletal component comparisons would be 
useful as there were only two shared between the two models, LMNA and KRT5, and 
these were oppositely regulated. The environment in which each model was maintained 
was very different and surely influences the cytoskeletal components needed to maintain 
adhesion and structure of the cells, suggesting explanation for differences occurring. The 
RNA processing proteins were oppositely regulated which could also be a consequence 
of their environments. Perhaps the cell line has increased production of more transcripts 
due to the lack of negative regulation from surrounding cell types, or they may actually 
require the extra transcripts due to the lack of paracrine factors or other needs due to 
environment. 
This comparison shows that HC11 cells, which are currently widely used to investigate 
events occurring in the MEC, may need to be analyzed more closely before trusting 
accuracy of findings. This study showed a striking difference in RNA processing and 
cytoskeletal dynamics between this cell line and primary MEC and some subtle yet 
meaningful differences in energy metabolism, which is reason to question the accuracy of 
the HC11 cell line to use as a model for certain aspects of MEC differentiation. 
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CHAPTER 3 – Proteomic analysis of isolated primary virgin, pregnant and primiparous 
quiescent mammary epithelial cells  
3.1 Introduction 
Investigation of the molecular events occurring throughout mammary development is an 
important and heavily studied topic because of its potential influence on the dairy 
industry, breast feeding, and the fight against breast cancer. Technologies aimed at 
obtaining large and undefined data sets such as microarrays and 2DGE have been used to 
analyze the changes occurring in the gland, which provide the ability to discover new 
molecules and processes involved that were previously not connected to mammary 
development. Most of these studies perform analysis on RNA or protein extracts obtained 
from whole tissue, which includes all information from not only the parenchyma but also 
the adipose, immune cells, endothelium and extracellular matrix (Rudolph et al., 2003; 
D’cruz et al., 2002; Beddek et al., 2003). This approach provides insight into changes in 
the entire gland, but does not give a clear picture of events occurring in the mammary 
epithelial cells and requirements for their differentiation into lactating cells. Other –omic 
investigations have analyzed changes during the differentiation of cell lines, such as the 
murine HC11 and the bovine MAC-T lines (Desrivieres et al., 2003; Strand, 2012). Data 
provided by these studies is more representative of the MEC itself, but there are also 
limitations of analyzing cell lines and in vitro experimental data. Cell lines have potential 
of changing over time and expressing transcripts and proteins unrepresentative of primary 
MEC and any data obtained in vitro is generated lacking influence from surrounding 
tissues and the natural environment for the MEC. Analysis of primary MEC from 
different stages of mammary development would eliminate the limitations of in vitro and 
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whole gland investigations by being representative of the MEC and receiving cues from 
their true environment throughout development. 
Previous investigation into changes occurring between pregnant and lactating states of 
the primary murine MEC has been performed in the Peterson lab (Strand, 2012). Results 
of this previous investigation were compared with the in vitro induction of a 
differentiated-like state of the HC11 murine MEC line by hormone treatment to elucidate 
similarities and differences between these two models of MEC differentiation; this 
comparison was discussed in the previous chapter. Changes in the mammary gland and 
MEC occur between all stages of development including from the virgin state to the 
pregnant state and from the lactating state back to quiescence. The following 
investigation aims to add to the data set from primary isolated MEC in different stages of 
mammary development. Primary MEC from the virgin state are isolated and compared to 
MEC from the pregnant state and primiparous quiescent state of the gland. The discovery 
of protein changes will add to the knowledge of the events that occur in preparation for 
the shift to a lactating phenotype and unveil changes in protein expression that persist in 
the MEC after full development, function, and involution of the mammary gland.  
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3.2 Methods 
3.2.1 Animals and breeding 
All procedures were approved by the Cal Poly Institutional Animal Care and Use 
Committee. ICR mice (Taconic, Hudson, NY) were housed with a 12 h light schedule 
and ad libitum access to food and water. Samples were taken from virgin and pregnant 
mice between 10 and 11 weeks of age. Pregnant samples were taken at day 10 of 
pregnancy. Due to resource and scheduling constraints, primiparous samples were taken 
from mice approximately 23 weeks in age. Primiparous mice were weaned at 21 days of 
lactation and samples were taken at 18 days post-weaning. Estrous cycle was not taken 
into account for virgin or primiparous samples. All mice were euthanized by CO2 
asphyxiation followed by cervical dislocation. Mammary tissue was harvested from all 
glands. Samples consisted of all glands pooled from one mouse. Three samples for each 
stage of development were used. 
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3.2.2 Primary mammary epithelial cell isolation 
Immediately following euthanasia all mammary tissue was removed and rinsed in 1X 
Hank’s Balanced Salt Solution. Tissue was then transferred and minced in digestion 
media containing collagenase, trypsin and EDTA in Dulbecco’s Modified Eagle Medium. 
Media containing tissue was placed in an incubated shaker set at 37°C for 90 minutes, 
with disruption by pipet every 30 minutes. Cells were pelleted and red blood cells were 
removed by incubation with blood cell lysis buffer (8.3 g/L ammonium chloride in 0.01M 
Tris-HCl). The remaining pellet was then plated in T-75 flasks for one hour in order to 
remove the rapidly adherent fibroblasts. The cell suspension was then incubated with 
EDTA and DNase solutions before being filtered through a 100um filter. Epithelial cells 
were re-suspended in DMSO cell freezing media, brought down to -80°C and stored in a 
liquid nitrogen tank until extraction. 
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3.2.3 Protein extraction 
Protein extractions were performed the same as was specified in section 2.2.2. 
 
3.2.4 Two-dimensional gel electrophoresis (2DGE) 
Two-dimensional gel electrophoresis was performed the same was as specified in section 
2.2.3. 
 
3.2.5 Gel analysis, spot picking and trypsin digestion 
Gel analysis, spot picking and trypsin digestion were performed the same as specified in 
section 2.2.4.  
 
3.2.6 Mass spectrometry and protein identification 
Mass spectrometry and protein identification were performed the same as specified in 
section 2.2.5. 
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3.3 Results 
All gels containing virgin, pregnant, and primiparous quiescent primary cell protein 
extracts were scanned and overlaid, creating one fused image for use in spot detection. 
Delta2D analysis of the fused gel image detected a total of 234 individual protein spots 
(Figure 4). Comparisons were then made between the virgin and pregnant gels and 
between the virgin and primiparous quiescent gels. Of the detected spots, 67 and 73 of 
these spots differed in abundance between the virgin and pregnant sample comparison 
and the virgin and quiescent sample comparison, respectively (P < 0.02). Of these 
differentially expressed spots, 31 and 36 were identified for the virgin and pregnant 
comparison (Table 2) and the virgin and quiescent comparison (Table 3), respectively 
when using the MASCOT server and matching the spectra to the NCBI Database. Of the 
31 identified proteins in the virgin and pregnant comparison, 3 were up and 28 were 
down regulated in the pregnant MEC relative to the virgin MEC. Of the 36 identified 
proteins in the virgin and pregnant comparison, 5 were up regulated and 31 were down 
regulated in the primiparous quiescent MEC relative to the virgin MEC. 
Functional groups for the majority of the identified differentially expressed proteins in 
the virgin and pregnant MEC comparison include energy metabolism (11 spots total; 1 up 
regulated/10 down regulated), cytoskeletal dynamics (7 spots total; 1 up regulated/6 
down regulated), and protein synthesis and processing (6 spots total; 1 up regulated/5 
down regulated).  
Functional groups for the majority of the identified differentially expressed proteins in 
the virgin and primiparous quiescent MEC comparison include energy metabolism (9 
spots total; 1 up regulated/ 8 down regulated), cytoskeletal dynamics (7 spots total; 3 up 
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regulated/4 down regulated), protein synthesis and processing (9 spots total; 1 up 
regulated/8 down regulated), and transcriptional regulation and RNA processing (3 spots 
total; all down regulated). 
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Figure 4. Fused gel image of isolated primary mammary epithelial cell protein spots. 
Protein was extracted from isolated primary virgin, pregnant, and primiparous quiescent 
mouse mammary epithelial cells. Proteins were subjected to 2-dimensional gel 
electrophoresis, stained with Coomassie blue, and analyzed by Delta 2D. The image 
represents all gels fused into one image. Labeled spots were differentially expressed 
between treatments (P < 0.02). Numbers correspond to “Spot ID” in Table 2 and Table 3. 
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Figure 5. Heat map of protein spots that were 
differentially expressed between isolated primary 
MEC from virgin and pregnant mice. Created by 
hierarchical clustering using Pearson’s correlation of 
HC11 protein spots that were differentially expressed 
between the undifferentiated and differentiated states 
(P < 0.02). Blue represents lower than average 
protein abundance, while orange represents higher 
than average protein abundance for that particular 
spot. Rows represent individual spots and the 
numbers correspond to “Spot ID” in Table 2. 
Columns represent individual gels. Virgin treatment 
gels are on the left and pregnant treatment gels are on 
the right.  
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Figure 6. Heat map of protein spots that were 
differentially expressed between isolated primary MEC 
from virgin and primiparous quiescent mice. Created by 
hierarchical clustering using Pearson’s correlation of 
HC11 protein spots that were differentially expressed 
between the undifferentiated and differentiated states (P 
< 0.02). Blue represents lower than average protein 
abundance, while orange represents higher than average 
protein abundance for that particular spot. Rows 
represent individual spots and the numbers correspond 
to “Spot ID” in Table 3. Columns represent individual 
gels. Virgin treatment gels are on the left and 
primiparous quiescent treatment gels are on the right.  
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Table 2.  List of identified protein spots that were differentially expressed between 
isolated primary virgin and pregnant MECs (P < 0.02). Under “Direction of Regulation,” 
“up” indicates an increased abundance of the specified protein, while “down” means the 
decreased abundance of the specified protein in the pregnant cells relative to the virgin 
cells. “Fold change” indicates magnitude of abundance change and was calculated by 
dividing mean spot abundance of pregnant gels by mean spot abundance of virgin gels. 
Spot 
ID Protein Name 
Gene 
Name 
Direction 
of 
Regulation 
Fold 
change 
cytoskeleton 
95 keratin, type II cytoskeletal 1 Krt1 down 0.35 
151 keratin, type I cytoskeletal 16 Krt16 down 0.59 
194 keratin, type I cytoskeletal 19 Krt19 up 1.39 
19 LIM and SH3 domain protein 1 Lasp1 down 0.63 
93 prelamin-A/C isoform A precursor Lmna down 0.49 
105 lamin-B1 Lmnb1 down 0.69 
20 PDZ and LIM domain protein 1 Pdlim1 down 0.56 
immune function 
230 catalase Cat down 0.47 
202 immunoglobulin heavy chain variable region Ighvdj down 0.73 
ion transport 
2 voltage-dependent anion channel 2 Vdac2 down 0.64 
metabolism 
193 long-chain specific acyl-CoA dehydrogenase, mitochondrial precursor Acadl up 1.65 
15 short-chain specific acyl-CoA dehydrogenase Acads down 0.75 
40 acetyl-CoA acetyltransferase, mitochondrial precursor Acat1 down 0.71 
228 aconitate hydratase, mitochondrial precursor Aco2 down 0.56 
234 aconitate hydratase, mitochondrial precursor Aco2 down 0.66 
43 fructose-bisphosphate aldolase A isoform 1 precursor Aldoa down 0.68 
28 
electron transfer flavoprotein subunit alpha, 
mitochondrial Etfa down 0.46 
41 glyceraldehyde-3-phosphate dehydrogenase Gapdh down 0.64 
50 malate dehydrogenase Mdh2 down 0.55 
224 transketolase Tkt down 0.79 
92 heat shock protein 75 kDa, mitochondrial Trap1 down 0.56 
plasma protein 
103 alpha-fetoprotein, partial Afp down 0.58 
100 serum albumin Alb down 0.53 
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Spot 
ID Protein Name 
Gene 
Name 
Direction 
of 
Regulation 
Fold 
change 
160 serum albumin Alb down 0.52 
72 serotransferrin precursor Tf down 0.46 
protein synthesis & processing 
102 heat shock protein 1A Hspa1a down 0.40 
82 heat shock protein 70 cognate Hspa8 up 3.74 
117 alpha-1-antiproteinase precursor SERPINA1 down 0.53 
122 alpha-1-antiproteinase precursor SERPINA1 down 0.50 
135 alpha-1-antiproteinase precursor SERPINA1 down 0.41 
190 elongation factor Tu, mitochondrial isoform 2 Tufm down 0.72 
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Table 3.  List of identified protein spots that were differentially expressed between 
isolated primary virgin and primiparous quiescent MECs (P < 0.02). Under “Direction of 
Regulation,” “up” indicates an increased abundance of the specified protein, while 
“down” means the decreased abundance of the specified protein in the primiparous cells 
relative to the virgin cells. “Fold change” indicates magnitude of abundance change and 
was calculated by dividing mean spot abundance of primiparous quiescent gels by mean 
spot abundance of virgin gels. 
Spot 
ID Protein Name 
Gene 
Name 
Direction 
of 
Regulation 
Fold 
change 
cytoskeleton 
189 actin, cytoplasmic 1 Actb up 1.47 
192 actin, cytoplasmic 1 Actb up 2.34 
95 keratin, type II cytoskeletal 1 Krt1 down 0.59 
151 keratin, type I cytoskeletal 16 Krt16 down 0.51 
194 keratin, type I cytoskeletal 19 Krt19 up 1.87 
93 prelamin-A/C isoform A precursor  Lmna down 0.43 
20 PDZ and LIM domain protein 1 Pdlim1 down 0.55 
DNA replication & cell division 
25 cell division control protein 42 homolog  CDC42 down 0.36 
immune function 
202 immunoglobulin heavy chain variable region  Ighvdj down 0.60 
ion transport 
2 voltage-dependent anion channel 2 Vdac2 down 0.68 
metabolism 
15 short-chain specific acyl-CoA dehydrogenase Acads down 0.63 
234 aconitate hydratase, mitochondrial precursor  Aco2 down 0.61 
170 aldehyde dehydrogenase, mitochondrial precursor  Aldh2 down 0.48 
175 ATP synthase subunit beta, mitochondrial precursor  Atp5b down 0.55 
146 dihydrolipoamide dehydrogenase precursor  DLD down 0.46 
28 electron transfer flavoprotein subunit alpha, mitochondrial Etfa up 1.12 
38 fumarate hydratase, mitochondrial precursor  Fh down 0.81 
106 succinate dehydrogenase flavoprotein subunit Sdha down 0.34 
224 transketolase Tkt down 0.66 
plasma protein 
103 alpha-fetoprotein, partial  Afp down 0.60 
160 serum albumin Alb down 0.60 
72 serotransferrin precursor  Tf down 0.47 
75 serotransferrin precursor  Tf down 0.50 
84 serotransferrin Tf down 0.44 
protein synthesis & processing 
186 elongation factor 1-gamma  Eef1g down 0.42 
66 heat-shock protein 84 Hsp90ab1 down 0.48 
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Spot 
ID Protein Name 
Gene 
Name 
Direction 
of 
Regulation 
Fold 
change 
219 endoplasmin Hsp90b1 down 0.42 
82 heat shock protein 70 cognate Hspa8 up 3.93 
136 60 kDa heat shock protein, mitochondrial Hspd1 down 0.60 
122 alpha-1-antiproteinase precursor SERPINA1 down 0.72 
135 alpha-1-antiproteinase precursor SERPINA1 down 0.33 
119 alpha-1-antiproteinase precursor SERPINA1 down 0.40 
190 elongation factor Tu, mitochondrial isoform 2 Tufm down 0.45 
transcriptional regulation & RNA processing 
45 heterogeneous nuclear ribonucleoprotein A3  Hnrnpa3 down 0.55 
177 heterogeneous nuclear ribonucleoprotein H Hnrnph1 down 0.57 
69 far upstream element-binding protein 2 Khsrp down 0.65 
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3.4 Discussion 
In this study, the protein expression of primary isolated MECs from virgin mice was 
compared with that of primary isolated MECs from pregnant and primiparous quiescent 
mice of the same lineage. As previously mentioned, the methods of analysis used in 
2DGE allow the discovery of protein changes occurring at a point for each stage of 
development investigated, but only provide a fraction of all changes occurring. The 
results for this set of experiments included an even smaller fraction that expected. The 
small number of identifications could have been a result of low protein abundance in the 
samples run, as original protein concentration was lower than desired and the procedures 
had to be repeated several times due to technical difficulties. Another possibility, though 
not as likely, is that the proteins have not yet been identified and did not match any NCBI 
database information. This low number of protein identities must be kept in mind when 
reading the following discussion, as it is more difficult to put together a possible scenario 
occurring in the cell with such a small subset of information. This being said, the trend of 
down regulation in both comparisons relative to the virgin MECs is likely a true 
occurrence. In the virgin to pregnant comparison, only 10 of the 67 differentially 
expressed spots were up regulated in the pregnant MEC. In the virgin to primiparous 
quiescent comparison, only 19 of the 73 differentially expressed spots were up regulated 
in the primiparous MEC. The spots that were successfully identified closely mirrored this 
trend of down regulation from the virgin state with only 5 out of 36 and 3 out of 31 spots 
being up regulated in the pregnant and primparous MEC, respectively. 
In addition to the small data set, another variable to consider when reviewing the 
following information is the possibility of contaminating cell types. Though the aim of 
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the isolation procedures was to end up with isolated luminal mammary epithelial cells, 
there are many more cell types in the gland that could have remained in the final pellet. 
The most probable contaminating cell type would be myoepithelial cells, followed by 
endothelial cells and leukocytes. While the presence of adipocytes, fibroblasts, and 
erythrocytes is also possible, specific and effective steps were employed for their 
elimination and they possess phenotypes distinct from the MECs and were not seen when 
the cells were isolated and examined microscopically. 
One last consideration is the stage of the estrous cycle in which the virgin and 
primiparous quiescent mice were harvested. This factor was not monitored or confirmed 
on the date of harvest, resulting in no knowledge regarding in which stage samples were 
taken or consistency in stage of cycle across these different samples. As mentioned in 
chapter 1, the activity of the cells does change with stage in estrous cycle and this would 
very likely have an effect on the protein expression profile of these cells. 
Although there were disappointing limitations based on the data obtained, and the 
variables mentioned above must be considered when analyzing the resulting data, 
proposed scenarios based on the changes in the protein profiles in the different stages of 
development were very interesting. The seemingly high abundance of many protein types 
in the virgin MEC compared to both other stages of development were surprising and 
further investigation into this phenomenon would be a fascinating comparator.  A 
discussion of both comparisons performed and the possible events occurring in these cells 
will follow. 
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3.4.1 Virgin vs Pregnant Comparison 
3.4.1.1 Cytoskeleton 
All but one of the identified proteins related to cytoskeletal dynamics were down 
regulated from the virgin to the pregnant state. This may first seem surprising as it may 
seem that differentiating cells would require reorganization and increased cytoskeletal 
function would be required, but when the individual proteins are investigated a possible 
logical scenario is revealed. PDZ and LIM domain protein 1 (PDLIM1, also known as 
CLIM1) and LIM and SH3 domain protein 1 (LASP1) were both down regulated from 
the virgin to the pregnant state of the MEC. PDLIM1 has been found in close association 
with hormone receptor, ERα and is a co-regulator of ERα’s transcriptional targets. Its 
expression has been found very high in less-differentiated and aggressive breast tumors, 
and has also been found to block differentiation in several cell types, including MEC in 
vitro (Johnsen et al., 2009). LASP1 is an actin binding protein that is required for cell 
migration and is also highly expressed in breast tumors (Lin et al., 2004). The down 
regulation of these proteins in the primary pregnant MEC might indicate that the 
proliferation and reorganization of early pregnancy has ended and the differentiation of 
these cells into the lactating phenotype can be performed. Two lamin proteins were also 
down regulated in the pregnant state: prelamin A/C (LMNA) and lamin B1 (LMNB1). 
The lamin proteins have long been known as the major component of the nuclear lamina, 
providing structure and stability to the nuclear envelope as well as serve as anchor points 
for chromatin. Now they are thought to play other roles in processes such as DNA 
synthesis, transcription, and apoptosis (Goldman et al., 2002). The down regulation of 
these proteins is interesting, especially since the loss of LMNB1 has been associated with 
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cell senescence in previous investigations (Sadaie et al., 2013; Freund et al., 2012). Three 
keratins (KRT) were also identified. KRT1 and KRT16 were down regulated in the 
pregnant state, while KRT19 was one of the few proteins that were up regulated. KRT16 
has been reported as a normal resident of the mammary gland (Pellegrino et al., 1988), 
while it was surprising to see differential expression of KRT1, as previous investigation 
has reported it as being absent in all stages of mammary development (Mikaelian et al., 
2006). The up regulation of KRT19 was of interest due to the few proteins that showed 
this direction of expression. The increase in KRT19 in the pregnant state is in agreement 
with previous reports that its expression is highest during pregnancy and lactation. It is 
indicative of low proliferation and increased ability for milk component secretion, 
suggesting gland is in the differentiating stage following the spike in expansion 
mentioned in chapter 1 (Bartek et al., 1990). 
Overall, the differential expression of the cytoskeletal proteins from virgin to the 
pregnant state imply that the cells isolated from the pregnant glands are in the 
differentiating stage following the highly proliferative stage of early pregnancy with 
decreased motility and increased indicators of differentiation.  
 
3.4.1.2 Metabolism 
All proteins involved in metabolic processes were down regulated in the pregnant state 
compared with the virgin state with the exception of one. Long-chain specific acyl-CoA 
dehydrogenase (ACADL) was increased in expression in the pregnant primary MEC, 
while short chain acyl-CoA dehydrogenase was decreased. Though many proteins in 
metabolic processes were not identified and their direction of regulation is unaccounted 
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for, the proteins that were identified suggested mass decrease in energy metabolism 
compared to the virgin state.  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 
fructose-bisphosphate aldolase A (ALDOA) down regulation suggest decreased 
glycolysis. Whether there is a lower influx, a build up and storage of glucose, or use for 
other processes at this point in development cannot be determined by the data gathered, 
but it does not appear that glucose is entering glycolysis at as high of a rate as in the 
virgin MEC. The trend of lower energy generation continues with a decrease seen in 
dihydrolipoamide dehydrogenase, aconitate hydratase (ACO2), and malate 
dehydrogenase, which function in the conversion of pyruvate to acetyl CoA and the TCA 
cycle. Malate dehydrogenase can also aid in the generation of NADPH, which also may 
be decreased based on the down regulation of transketolase, a member of the pentose 
phosphate shunt. The trend suggests that less energy generation is occurring in the 
pregnant state than the virgin state, possibly suggesting that differentiated state of the cell 
is more energy efficient. One last protein is a member of the heat shock proteins, but has 
been shown to have regulatory effects on metabolism. Heat shock protein 75 kDa 
(TRAP1) is down regulated in the pregnant state relative to the virgin state. This is 
interesting because of a previous report that deficiency in TRAP1 leads to an increase in 
mitochondrial respiration, fatty acid oxidation, and a buildup of TCA cycle intermediates, 
ATP and reactive oxygen species (ROS), while also suppressing glucose metabolism. In 
addition to metabolic effects, its decrease is also associated with increased cell 
invasiveness (Yoshida et al., 2013). While there is no evidence of increased respiration 
and fatty acid oxidation in our data, there is also no evidence of its suppression and there 
is evidence of suppression of glycolysis. The decrease in TRAP1 may be partially 
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responsible for depression of glucose metabolism in this investigation, though the 
cytoskeletal evidence suggests increased stability and polarization rather than mobility 
and invasiveness. 
Overall the interesting trend of metabolic processes was a decrease in activity in the 
pregnant state of the cell, which means it was high in the virgin state. This is an 
interesting phenomenon that might be explained in several ways. Perhaps the virgin MEC 
requires more energy use due to the fluctuations in proliferation and regression seen with 
the estrous cycle, or maybe the difference in available nutrients in the blood stream due to 
the hormones of pregnancy has an effect on metabolic regulation and the use of glucose 
in the two states of the cell. 
 
3.4.1.3 Protein synthesis and processing 
In addition to the TRAP1, two other heat shock proteins were identified as differentially 
expressed in this comparison. Heath shock protein 1A (HSPA1A) is down regulated in 
the pregnant MEC. This is a stress-induced HSP and helps the cell manage aggregation of 
denatured proteins in stress conditions. In contrast, heat shock protein 70 cognate 
(HSPA8) was up regulated in the pregnant MEC. This protein is 86% identical to 
HSPA1A, but is a constitutively expressed protein that acts as a housekeeper for the cell, 
aiding in protein folding and transport as well as managing denatured protein aggregation 
in times other than just high stress (Daugaard et al., 2007). Perhaps the up regulation of 
HSPA8 balances the decreased need for HSPA1A and the state of the pregnant MEC is in 
a less stressful state than the virgin MEC. Though not many proteins in this category 
were identified, the ones that were indicate a lower amount of protein relative to the 
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virgin state. Alpha-1-antiproteinase (SERPINA1) and elongation factor tu (TUFM) are 
both expressed at a lower level in the pregnant state than the virgin state. These proteins 
inhibit serine proteases and aid in the production of proteins by helping with the binding 
of tRNA at the ribosome, respectively (Kalsheker, 1988; Stark et al., 1997). This would 
allow increased protein degradation and decreased protein production, though these are 
only two of a multitude of proteins involved in these processes for which we do not know 
the direction of regulation. 
 
3.4.1.4 Secreted proteins 
Interestingly, there were several identified proteins that are secreted and typically found 
circulating in the plasma that were identified in this comparison. Albumin (ALB), alpha-
fetoprotein (AFP), and serotransferrin (TF) were all identified as down regulated in the 
pregnant state. The function of AFP is not well understood, though it is thought to be 
responsible for the transport of various ligands such as fatty acids and heavy metals. 
Roles as a growth promoter and a growth suppressor have both been assigned to this 
protein and it has been recognized as a protein present during pregnancy that has lasting 
protective effects from breast cancer risks (Vakharia and Mizejewski, 2000; Parikh et al., 
2005). This is very interesting since this protein was decreased in the pregnant state 
versus the virgin state of the MEC. The protein responsible for iron transport, TF, was 
also decreased in the pregnant state. This protein is typically found in milk product 
during lactation, but the decrease in pregnancy from the virgin state in this investigation 
might be explained by the decreased need of iron at that moment of cell isolation. Iron is 
required as a cofactor during DNA replication and growth, which, as previously 
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mentioned, might not be occurring in the pregnant MEC at their stage of development 
(Gomme and McCann, 2005). Albumin is also a component of the final milk product and 
though its down regulation from the virgin state might be surprising, the lack of up 
regulation is not as the inclusion of protein transport into the alveolar lumen may not yet 
have began.  
 
3.4.1.5 Other identified proteins 
Voltage-dependent anion channel 2 (VDAC2) was found decreased in abundance in the 
pregnant state relative to the virgin state of the MEC. This protein functions as an ion 
channel in the mitochondrial outer membrane and is responsible for transport of 
metabolites such as ATP and ADP across the membrane (Rostovtseva and Bezrukov, 
2008). Perhaps since the metabolism appears suppressed in the pregnant cells, the 
regulation and transport of metabolites is also reduced and VDAC2 is decreased due to 
lack of necessity. Another interesting expression profile of the pregnant state relative to 
the virgin state is the decrease in abundance of two proteins related to immune and stress-
fighting function. Catalase and immunoglobulin heavy chain, variable region (IGHVDJ) 
were both found down regulated in the pregnant MEC. Catalase is responsible for 
protection against reactive oxygen species and IGHVDJ is the heavy chain portion of 
immunoglobulin. The decrease in catalase agrees with the story told by the heat shock 
proteins, that possibly the pregnant MEC does not require as much of this protein due to a 
less stressful state. It is interesting that IGHVDJ is not only present in the virgin and 
pregnant cells, but that it varies in regulation as this protein is only produced by B cells of 
the immune system. Immunoglobulins are transported from the blood into the final milk 
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product, but this was thought to occur near parturition. The explanation of a 
contaminating cell type during the virgin isolation should not be overlooked in this 
situation. 
 
3.4.2 Virgin vs Primiparous Quiescent Comparison  
3.4.2.1 Cytoskeleton 
The identified cytoskeletal protein expression profile for the primiparous quiescent MEC 
varies only slightly from the pregnant MEC relative to the virgin state of the cells. 
LASP1 and LMNB1 were the only two present in the virgin/pregnant comparison that 
were not identified as differentially expressed between the primiparous quiescent and 
virgin states. PDLIM1, LMNA, and the keratins (1, 16, 19) all show the same direction of 
regulation as seen in the virgin/pregnant comparison above. This similar expression 
pattern for the pregnant and quiescent states relative to the virgin state appear to represent 
persisting differences in the MEC after one pregnancy and lactation event. Since 
PDLIM1 has been implicated in aggressiveness of breast cancer (Johnsen et al., 2009), 
this continued decrease in abundance could support the idea that it may play a role in 
tumor metastases and decreased risk following a pregnancy. In the same way, the 
increased expression of KRT19 indicates a continued state of a higher order of 
differentiation, which has been seen histologically and is a well-documented 
phenomenon (Bartek et al., 1990; Richert et al., 2000; Daniel and Silberstein, 1987). In 
addition to the proteins that were identified in the previous comparison, actin, 
cytoplasmic 1 (ββ-actin; ACTB) also appeared as up regulated in the quiescent state 
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relative to the virgin state. Increased actin is surprising as it indicates cell movement or 
cytoskeletal rearrangement. Perhaps as beta-actin was increased in the differentiated 
HC11 cells, the quiescent cells have persisting cytoskeletal changes from the previously 
lactating phenotype in which the cytoskeletal rearrangement was necessary for transport 
of milk components to the alveolar lumen. 
 
3.4.2.2 Metabolism 
The metabolic state of the primiparous quiescent MEC appears to be suppressed relative 
to the virgin state of the cells. The glycolytic enzymes identified in the last comparison 
were not indicated as differentially expressed between the virgin and primiparous 
quiescent states, so the regulation of this pathway in this investigation cannot be 
speculated upon. Enzymes involved in the TCA cycle and respiratory chain, however, 
were identified. Dihydrolipoamide dehydrogenase (DLD) is on of three enzymes that 
makes up the pyruvate dehydrogenase complex which converts pyruvate to acetyl CoA 
for entrance into the TCA cycle (Patel and Korotchkina, 2006). This means that there is 
either a lower amount of acetyl CoA entering the TCA cycle or the substrate is coming 
from another origin. DLD also plays a role in the conversion of 2-oxoglutarate to 
succinyl-CoA in the TCA cycle. Aconitate hydratase (ACO2), succinate dehydrogenase 
flavoprotein subunit (SDHA), and fumarate hydratase (FH) are also all down regulated 
relative to the virgin state. These all catalyze reactions of the TCA cycle. SDHA links the 
TCA cycle to the respiratory chain. In addition to the TCA cycle link being decreased,   
ATP synthase subunit beta is down regulated in the primiparous state. This is a part of the 
F1, catalytic portion of the ATP synthase enzyme and required for the production of ATP 
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in the respiratory chain (Wang and Oster, 1998). Interestingly, the only identified protein 
that was differentially expressed in both comparisons, but displayed opposite directions 
of regulation was electron transfer flavoprotein subunit alpha (ETFA). Increased 
abundance of ETFA in the primiparous state relative to the virgin state was detected in 
this investigation, while it was down regulated in the pregnant state relative to the virgin 
state. The role of ETFA is to transfer electrons from several dehydrogenases to the 
respiratory chain (Toogood et al., 2007). The increase in this protein and decrease in 
ATP5B suggests an interesting contrast in respiratory activity. Production of NADPH 
might also be reduced in the primiparous state as one of the major PPS enzymes, TKT, is 
down regulated. Perhaps the lipid metabolism pathways are suppressed altogether, as the 
ACADS is also reduced in this state. Aldehyde dehydrogenase (ALDH2) is the last 
identified metabolic protein that is down regulated in the primiparous state. Though 
mostly known for alcohol metabolism, ALDH2 can also participate in other metabolic 
processes such as the series of reactions resulting in the conversion of threonine to 
pyruvate (Salway, 1994), which was a proposed reason for its up regulation in 
differentiated HC11 cells in the previous chapter.  
Overall metabolic activity in the primiparous quiescent MEC relative to the virgin MEC 
reveals a suppression of activity, much like what was seen in the virgin/pregnant 
comparison. This with the similarities in cytoskeletal proteins, which indicated a higher 
order of differentiation may suggest the greater requirement for energy by the less 
differentiated, virgin state of the cell.  
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3.4.2.3 Protein synthesis and processing 
Similar to the previous comparison, HSPA8 was up regulated from the virgin state to the 
primiparous state. Heat shock protein 84 (HSP90AB1), endoplasmin (HSP90B1), and 60 
kDa heat shock protein (HSPD1) were all down regulated in the primiparous state. 
HSP90B1 and HSPD1 function in the endoplasmic reticulum and the mitochondria, 
respectively, to participate in protein folding and transport (Chen et al. 2005; Koll et al., 
1992). The cytosolic HSP90AB1 is constitutively expressed and involved in folding of 
cell regulatory proteins and refolding of stress-denatured proteins (Chen et al., 2005). 
Perhaps the up regulation of HSPA8 was enough to regulate stress-denatured proteins and 
the need for folding of cell regulatory proteins was decreased in the non-proliferative 
state of the primiparous relative to the virgin MEC. Elongation factor 1-gamma (EEF1G) 
and TUFM were also both down regulated in the primiparous MEC. This indicates 
decreased translation as these elongation factors aid in the delivery of tRNAs to the 
ribosome to allow production of proteins. Lastly, SERPINA1 was again found down 
regulated relative to the virgin state of the MEC. Just as in the pregnant MEC, the 
regulation of the identified proteins related to protein processing occurring in the 
primiparous MEC suggested a less stressful environment with decreased protein 
production and the potential for increased degradation.  
 
3.4.2.4 Transcriptional regulation and RNA processing  
In addition to the decrease in protein abundance, three proteins involved in transcriptional 
regulatory processes were also down regulated. Two heterogeneous nuclear 
ribonucleoprotein members, A3 and H, were decreased in abundance in the primiparous 
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state relative to the virgin state. These proteins are involved in the cytoplasmic trafficking 
of RNA, pre-RNA processing, and mRNA maturation (Ma et al., 2002; Papadopoulou et 
al., 2012; Bent et al., 1995). Far upstream element-binding protein 2 (KHSRP) is also 
decreased in primiparous cells. This protein participates in RNA splicing and plays a role 
in the production of micro RNA that leads to gene regulation (Treiber et al., 2012). 
Though only three proteins in this category were identified, the indication from their 
regulation and the regulation of protein processing is a decrease in production of 
transcripts and proteins in the primiparous MEC relative to the virgin state.  
 
3.4.2.5 Secreted proteins 
Just as in the pregnant/virgin comparison, several typically secreted proteins were 
identified and decreased in abundance in the primiparous MEC relative to the virgin state 
of the cell. Albumin, AFP and TF were once again all identified as higher in the virgin. 
Since the same pattern is seen in the pregnant cells as the primiparous cells relative to 
virgin MEC, the question then shifts focus to why the virgin state might be displaying 
higher levels of these proteins, especially AFP which is supposed to be highest in 
pregnancy and is reported to have lasting effects on decreased risk of breast cancer 
(Vakharia and Mizejewski, 2000; Parikh et al., 2005). The decrease in TF might be 
explained in the same manner as it was for the pregnant state - iron is required as a 
cofactor during DNA replication and growth, which might not be occurring as often in 
primiparous MEC as in virgin MEC (Gomme and McCann, 2005). The abundance of 
albumin in the virgin state is still surprising and further investigations would help reveal 
whether this pattern of expression is consistent and served a purpose.  
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3.4.2.6 Other identified proteins 
Voltage dependent anion channel 2 and IGHVDJ were both also down regulated in the 
primiparous MEC relative to the virgin MEC. Without more information about other 
related proteins, limited speculation can be made on their roles in the virgin cells, though 
the previous proposed explanation for decreased VDAC2 goes along with the seeming 
reduction in metabolism in the primiparous MEC relative to the virgin as well. A reduced 
metabolic load of the mitochondria may lack the need of more VDAC2 in the 
primiparous cells. One other protein of interest was not found as differing in abundance 
between virgin and pregnant states. Cell division cycle 42 (CDC42) is a protein that plays 
a role in cell cycle progression, cell polarity, migration and differentiation and has 
recently reported as required for MEC morphogenesis in vitro (Bray et al., 2011). This 
protein is also overexpressed in certain breast cancer types (Fritz et al., 2002). The down 
regulation of this protein from the virgin to the primiparous state of the MEC might be an 
interesting further investigation, as it has already been implicated in the possible role of 
hyper-proliferation and migration of cancer cells (Bray et al., 2013). 
 
3.4.3 Comparison to Previous Studies 
As mentioned previously, an investigation much like the one reported in this chapter has 
been performed in the same lab on isolated primary pregnant MEC compared with 
lactating MEC (Strand, 2012). Many identified proteins in the two comparisons were 
shared, though their regulation varied among them. The comparison between the 
pregnant and lactating states of the primary MECs showed largely up regulated metabolic 
processes. Many enzymes involved in fatty acid synthesis, the TCA cycle and the 
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respiratory chain were increased from the pregnant to the lactating state. This would be 
expected due to the high demand of the cell to produce and transport components into the 
alveolar lumen. An interesting comparison would be that of the virgin MEC and lactating 
MEC, as the pregnant MEC appeared to have decreased metabolic activity relative to the 
virgin cells.  The down regulation of the cytoskeletal proteins, LASP1 and PDLIM1, was 
also seen in the previous pregnant/lactating comparison as it was in the virgin/pregnant 
comparison. This indicates that they are highest in the virgin state of the MEC, which 
may be an interesting topic of investigation due to the prior reports of high expression of 
these proteins relating to breast cancer (Johnsen et al., 2009; Lin et al., 2004). Patterns of 
protein synthesis and processing were similar to what was found in the HC11 in vitro 
investigation discussed in Chapter 2. Protein processing was down in lactating MEC even 
from pregnant MEC, which again indicates the high levels of protein synthesis and 
processing in the virgin MEC. A study examining the comparisons between many states 
of development in one data set would be very useful in finding changes and trends of 
protein category expression profiles among these MEC. 
As mentioned in Chapter 1, D’Cruz and colleagues performed a microarray on parous vs. 
nulliparous rodent glands and found decreased expression of transcripts involved in 
proliferation and increased expression of genes involved in growth inhibition. Similar 
results were found by Ginger and colleagues when the expression profile of rats without 
exposure to gestational hormones was compared to rats that had previously been 
subjected to induced pregnancy through E and P levels (2001). In addition they found 
differences in metabolic genes and genes involved in cell-cell contact and the ECM. 
Balogh et al studied the breast tissue from nulliparous and parous women (2006). This 
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study also found evidence of increased immune surveillance and proliferation inhibition 
through apoptotic factors in parous breast tissue as well as changes in genes involved in 
cell trafficking, cell signaling, transcription and translation, and others.  These 
investigations were performed on whole tissue from the breast, whereas the study 
recorded here was performed on isolated mammary epithelial cells. Though the 
possibility of contamination with other cell types of the mammary gland is not negligible, 
the data is likely more indicative of the molecular occurrences in that particular cell type 
than the others.  
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CHAPTER 4 – Development of a database for organization and analysis of mammary 
epithelial cell data: BROVINE 
4.1 Introduction  
In today’s world of seemingly limitless ability for data generation from the scientific 
community, making sense of the vast sea of information is the largest obstacle. The 
ability of experts from different fields to communicate effectively and work together has 
become more important with this surge of data generation and the need for 
interdisciplinary communication is recognized and well documented (Wolkenhauer and 
Hofmeyr, 2013; NRC, 2010; Howe et al., 2008). Computer programs are needed for 
storing, organizing, and analyzing these large data sets and the scientists that produce this 
data are not likely capable of creating the advanced programs needed. The Peterson lab’s 
investigation into the changing MEC through different stages of development has 
generated relatively small data sets that include lists of protein names that have changed 
in expression levels from one state to the next. The lists are growing and the desire to find 
relationships among the proteins on these different lists is a difficult achievement due the 
number of them present. A computer could accomplish this process much more quickly 
and easily than a human – if the right program existed.  
The Peterson lab collaborated with Dr. Alex Dekhtyar from the computer science 
department in order to create a program that could help organize and analyze the data sets 
being produced. The aim of the database is to help unveil potential transcriptional 
regulators of mammary development by using lists of proteins, or their associated genes, 
that are differentially expressed between different stages of development in the MEC. 
Lists of potential transcription factors (TFs) for each differentially expressed gene are 
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generated with an online tool and this information needs to be managed as well. Ideally, 
the database would aid in upload and organization of data from many experiments 
performed in any species looking at any stage of mammary development. The database 
would then be responsible for organizing and analyzing these lists of genes and 
corresponding TFs to uncover relationships among species, genes, and the regulation 
patterns of these genes. 
The following chapter may not be typical of a scientific paper as it is not filled with data 
sets and facts, rather a discussion regarding the personal experience of interdisciplinary 
learning and a tour of the end product. It discusses different steps taken and progress that 
has been made to begin development of software that can aid in the analysis of the MEC 
data sets being generated more quickly and in more depth than would otherwise be 
possible.  
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4.2 Methods 
4.2.1 BIO 441 
My participation in this class occurred after my participation in CSC 366 (described 
below), however, the information learned in this class would have been very useful prior 
to my involvement in CSC 366 so it will be explained first. The class was taught by Dr. 
Anya Goodman and included lecture and lab. It was split into two major learning 
objectives; students learned to annotate genes and participated in the Genomics 
Education Partnership by annotating a portion of the Drosphilia melanogaster genome, 
and they worked with computer science students to create computer programs that 
performed tasks related to genome assembly and analysis. The lab was typically held 
with computer science students from CS 448 taught by Dr. Alex Dekhtyar. The two 
classes were first taught basics of the others’ discipline to provide background knowledge 
that would help with the collaboration that took place during lab sessions. Teams of BIO 
441 students wrote program requirements outlining desired functionality for computer 
programs and CS 448 students wrote code to create said programs. As each portion was 
completed, the BIO 441 students would run tests and report back to the CS students in 
order to fix bugs found in the programs until their performance was satisfactory. The 
process of software development was introduced to BIO students in this way while CS 
students gained experience with a real client outside of the discipline. 
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4.2.2 CSC 366 
To begin development of the database desired for the Peterson lab’s growing data set, we 
became the clients for Dr. Alex Dekhtyar’s class of computer science students (CSC 366) 
whose job was to produce our desired product. The class began with a brief lesson on 
genetics and transcriptional regulation to give the CS students a background for the 
database needed for our project. In order for our desired program plan to be conveyed 
properly to the CS students, terms needed to be defined and exact functions needed to be 
specified so the developers knew what code they needed to write; we constructed a 
document containing use cases, which outlined the steps describing our desired 
interactions with the program. The document outlined specifics regarding data insertion 
and manipulation functionality, browsing and filtering functionality, and analytical 
functionality (see Appendix A). From that point the class broke into teams and each team 
was in charge of developing prototypes of the product we requested. The developers used 
our document to formulate requirements and begin to design the software. As portions of 
the database were implemented they were tested with initial data we provided. 
Adjustments were made based off of bugs found during testing and clarifications of 
desired functionalities. At the end of the class, the complete database products were 
presented to us and one was chosen for further development. The database chosen was 
web-based and was named “Brovine” by the developing team. It was developed by a 
team of men and it was developed using data from a bovine cell line, which led to the 
developers naming the program “Brovine.”  
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4.2.3 Individual database development  
The desired functionality of the database went beyond the scope of the CSC 366 class. 
One team member, Therin Irwin, that helped create Brovine continued development of 
the database through individual consultation with the Peterson Lab as his senior project. 
Further improvements were implemented in a similar manner. Documents similar in form 
to the use case document presented in Appendix A were written containing desired 
functionalities. Requirements were then formulated and the new code was written. The 
new portions of the program were then tested by the Peterson lab and a report was sent 
back with any bugs detected or changes desired.  
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4.2.4 Data Preparation 
The data used to develop the database was generated by a 2DGE experiment performed 
by former lab mate, Laura Strand. A bovine cell line, MAC-T was cultured and protein 
was extracted and analyzed in the undifferentiated and differentiated states. Differentially 
expressed proteins between the two states were identified and a list was generated. 
Promoter regions for the genes of this list of differentially expressed proteins were 
obtained from their associated gene sequence found on the NCBI genome database, 
starting 1950 nucleotides before the transcription start site and ending 50 nucleotides 
after the transcription start site. Lists of transcription factors associated with each of these 
genes were generated using Transcription Element Search System (TESS). TESS was an 
available online tool that identified potential transcription factors for a gene based on 
presence of the TF’s regulatory elements in a provided sequence. The resulting product 
was an excel file containing worksheets listing the search parameters used and the 
potential TFs associated with the provided promoter sequence. These excel files were 
then converted to .csv files to allow loading into the developing databases in CSC 366. 
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4.3 Results 
At the end of the CSC 366 class, all use case specifications (Appendix A) excluding the 
extra credit items were completed by many of the developed databases including the 
chosen database, Brovine. These included pages labeled Upload, Experiment Hierarchy, 
Gene Summary, TF Summary, Gene Search, and TF Popularity. 
After continued development with Therin Irwin, existing pages were updated further and 
a page labeled TF Subtract was added. The following were the final pages containing the 
most important functionalities and their descriptions: 
1. Upload – The upload page of the Brovine database allows individual gene or bulk 
file upload into the web-based database. The user is able to browse the files on their 
computer to upload into the database. Files are uploaded in .csv format, which are 
converted from excel files. A snapshot of this page is shown in Figure 7.  
 
 
 
 
 
 
 
 
 
 
Figure 7. Upload page of the Brovine database.  	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2. Experimental Hierarchy – The experimental hierarchy page allows the used to filter 
down through the uploaded data to find information on specific known entities. The 
flow of the information begins with a choice of species, followed by comparison, 
followed by experiment, followed by gene, followed by transcription factor, 
followed by regulatory sequence. When a regulatory sequence is selected, more 
information about it is displayed including the start position, its length, the sense, 
and the exact nucleotide sequence. This page also allows editing of the information 
that was uploaded as well as the ability to hide information. A snapshot of this page 
is shown in Figure 8.  
 
Figure 8. Experiment Hierarchy page of the Brovine database. 
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3. Gene Summary – This page provides a list of all genes populating the database in a 
table form. Information provided in the table includes the gene name and 
abbreviation, the number of comparisons in which the gene is found, and the number 
of experiments in which the gene is found. The table is sortable by any column. 
When a gene is selected, another table appears listing the experiments in which the 
gene is found and the following information found in that experiment: the 
corresponding comparison and species, the gene’s regulation in that experiment, and 
the position of the gene in that species’ genome. The second table listing the 
experiments can be filtered by regulation. A snapshot of this page is shown in Figure 
9. 
 
 
 
 
Figure 9. Gene Summary page of the Brovine database. 
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4. TF Summary – This page provides a list of all transcription factors populating the 
database in a table form. Information provided in the table includes the TF name, the 
number of genes in which the TF is found, and the total number of occurrences of 
the TF in the database. The table is sortable by any column. When a TF is selected, 
another table appears listing the occurrences and including the following information 
about each one: the length and sense and beginning position of the sequence, the 
species, comparison and experiment the occurrence exists, the gene in which it was 
found and that gene’s regulation in the corresponding experiment. The second table 
listing the occurrences can be filtered by regulation. A snapshot of this page is 
shown in Figure 10. 
  
 
Figure 10. TF Summary page of the Brovine database. 
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5. Gene Search – This page allows the user to select any number species, comparisons 
and experiments to provide a list of TF present in the selected categories. The user 
can then select any number of specific TFs from this list and specify filtering 
options. The database will then use these selections to provide a list of genes 
containing all of the selected TFs that meet the filtering requirements. A snapshot of 
this page is shown in Figure 11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Gene Search page of the Brovine database. 
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6. TF Subtract – This page allows the user to select two separate groups of genes and 
subtract the TFs present in one group of genes from the list of TFs present in the 
other group of genes. This allows the user to find TFs that might have potential 
significance in an experimental group of differentially expressed genes by showing 
only the TFs that are present in the experimental comparison, but not in a control 
group of genes. The final list provided includes the TF names, the number of genes 
in which they appear, and their number of occurrences. A snapshot of this page is 
shown in Figure 12.  
Figure 12. TF Subtract page of the Brovine database. 
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4.4 Discussion 
Development of the database is not complete, but much has been accomplished. No 
publishable experimental results have been obtained from the database to this point. 
Further functionality is desired from this web-based program related to time course 
studies and regulation of genes sets throughout the duration of them. The TF Subtract 
page was a large advancement in this direction, but eventual development will aim at 
creating regulation profiles for different gene transcripts found at different time points of 
mammary development, grouping these genes based on their profiles, then using the 
functionality of the TF subtract page in order to find TFs that could potentially be driving 
the regulatory profiles of these groups of genes. When a few key TFs are found by the 
database that have potential of driving regulatory mechanisms of mammary development, 
experiments can be performed to confirm or refute these factors’ role in development.  
Other groups have designed software tools similar to the one we are attempting to 
generate. A description of other, similar tools follows. TFM-Explorer has the goal of 
identifying over-representation of transcription factor binding sites within a set of user-
defined genes (Tonon et al., 2010). This seems to be a useful tool for finding over-
represented transcription factors that works on the basis of probabilities of sequence 
presence, but does not appear to have a subtraction of a control set. Without the 
subtraction it would be hard to determine which transcription factors are important in 
solely the cell model in which the investigator is interested or in many models. 
CORE_TF performs a search for over-represented transcription factor binding sites based 
on user-provided ENSEMBL gene IDs and user-defined promoter regions (Hestand et al., 
2008). It presents a rather overwhelming table listing all identified binding sites in both 
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the control set of genes and the users’ genes of interest. This tool has a similar first goal 
of our database by finding binding sites taking into account a control set and has the 
ability of finding homologous genes. CARRIE is a tool that accomplishes goals very 
similar to ours, allowing the user to input microarray data and then proceeding to 
determine gene expression changes and identify likely transcription factor binding sites 
regulating the co-regulation of these genes. It also goes to the next step to construct 
regulatory networks, as is one of our final goals (Haverty et al., 2004). This database 
seems to be a great model for what we would like to accomplish, but with updated data 
input capabilities, as RNAseq is the new way to analyze gene expression, and additional 
ability to identify promoter patterns as mentioned above. We can use the lessons provided 
by these other tools to improve on their functionality in ours.   
The interdisciplinary collaboration experienced throughout the development of this 
database was extremely productive for all parties involved. The computer scientists and 
animal scientists were able to teach one another about their respective fields and the 
difficulties that can arise in the communication between the two disciplines was realized 
and eventually overcome. The Peterson lab was exposed to the process of software 
development and learned how to effectively communicate software requirements to the 
developers, including the level of specificity required. The computer scientists learned 
the importance of understanding the information they are working with and the basics of 
the field for which they are developing software. This real world experience should 
benefit all parties by giving them insight into the growing reality of interdisciplinary 
studies and the necessary collaboration between the technical and science fields. 
  
	  112 
 
LIST OF REFERENCES 
Abdul-Awal, et al., 1996. Ultrastructural and morphometrical studies on the endothelial 
cells of arteries supplying the abdomino-inguinal mammary gland of rats during the 
reproductive cycle. J Vet Med Sci 58(1):29-34. 
Alberts, et al., (eds.), 2002. Cell Junctions, Cell Adhesion, and the Extracellular Matrix. 
In Molecular Biology of the Cell. 4th edition. New York: Garland Science.  
Anderson, et al., 2007. Secretory activation in the mammary gland: it’s not just about 
milk protein synthesis! Breast Cancer Res 9(1):204. 
Andres and Djonov, 2010. The mammary gland vasculature revisited. J Mammary Gland 
Biol Neoplasia 15:319-328. 
Atabai, et al., 2007. Roles of the innate immune system in the mammary gland 
remodeling during involution. J Mammary Gland Biol Neoplasia 12(1):37-45. 
Auperlee, et al., 2013. Amphiregulin mediates progesterone-induced mammary ductal 
development during puberty. Breast Cancer Res 15(3):R44. 
Ball, et al., 1988. Prolactin regulation of beta-casein gene expression and of a cytosolic 
120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J 7(7):2089-
2095. 
Balogh, et al., 2006. Genomic signature induced by pregnancy in the human breast. Int J 
Oncol 28:399-410. 
Bartek et al., 1990. Keratin 19 expression in the adult and developing human mammary 
gland. Histochem J 22:537-544. 
Bauman and Vernon, 1993. Effects of exogenous bovine somatotropin on lactation. Annu 
Rev Nutr 13:437–461. 
	  113 
 
Beleut, et al., 2010. Two distinct mechanisms underlie progesterone-induced proliferation 
in the mammary gland. PNAS 107(7):2989-2994. 
Bent, et al., 1995. Heterogenous nuclear ribonucleoproteins H, H’, and F are members of 
a ubiquitously expressed subfamily of related but distinct proteins encoded by genes 
mapping to different chromosomes. J Biol Chem 270:28780-28789. 
Blachford, et al., 1995. Vectorial secretion by constitutive and regulated secretory 
pathways in mammary epithelial cells. Epith Cell Biol 4:8-16. 
Blaser, et al., 2003. Isolation of new splice isoforms, characterization and expression 
analysis of the human septin SEPT8. Gene 312:313-320. 
Boumahrou, et al., 2009. The major protein fraction of mouse milk revisited using proven 
proteomic tools. J Physiol Pharmacol 60(Suppl 3):113-118. 
Bourges, et al., 2008. New insights into the dual recruitment of IgA+ B cells in the 
developing mammary gland. Mol Immunol 45:3354-3362. 
Bray, et al., 2011. The Rho GTPase Cdc42 is required for mammary epithelial cell 
morphogenesis in vitro. Small GTPases 2:247–258. 
Bray et al., 2013. Cdc42 overexpression induces hyperbranching in the developing 
mammary gland by enhancing cell migration. Breast Cancer Res 15:R91. 
Brisken, et al., 1998. A paracrine role for the epithelial progesterone receptor in 
mammary gland development. Proc. Natl. Acad. Sci. 95: 5076–5081. 
Brisken, et al., 1999. Prolactin controls mammary gland development 
via direct and indirect mechanisms. Dev Biol 210:96-106. 
Brisken, et al., 2000. Essential function of Wnt-4 in mammary gland development 
downstream of progesterone signaling. Genes Dev 14(6):650-654. 
	  114 
 
Brisken, et al., 2002. IGF-2 Is a mediator of prolactin-induced morphogenesis in the 
breast. Dev Cell 3(6):877-887. 
Brisken, 2002. Hormonal control of alveolar development and its implications for breast 
carcinogenesis. J Mammary Gland Biol Neoplasia 7(1):39-48. 
Britt, et al., 2007. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 14:907-
933. 
Buratte and Buralle, 2008. Multiple roles of TDP-43 in gene expression, splicing 
regulation, and human disease. Front Biosci 13:867-878. 
Butcher, et al., 2009. A tense situation: Forcing tumour progression. Nat Rev Cancer 
9(2):108-122. 
Butte, et al., 1999. Adjustments in energy expenditure and substrate utilization during late 
pregnancy and lactation. Am J Clin Nutr 69:299–307. 
Byrne, et al., 2000. Identification of a hormone-responsive promoter immediately 
upstream of exon 1c in the human vitamin D receptor gene. Endocrinology 
141:2829–36. 
Capuco and Ellis, 2005. Bovine mammary progenitor cells: Current concepts 
and future directions. J Mammary Gland Biol Neoplasia. 10(1):5-15. 
Capuco, et al., 1999. Prolactin and growth hormone stimulation of lactation in mice 
requires thyroid hormones. Proc Soc Exp Biol Med 221(4):345-351. 
Cardiff and Allison, 2012. Mammary Gland. In Treuting and Dintzis (eds.), Comparative 
Anatomy and Histology: A Mouse and Human Atlas. Academic Press. 
Chen, et al. 2005. The HSP90 family of genes in the human genome: Insights into their 
divergence and evolution. Genomics 86:627-637. 
	  115 
 
Chen, et al., 2010. Akt is required for Stat5 activation and mammary differentiation. 
Breast Cancer Res 12:R72. 
Chen, et al., 2012. Autocrine prolactin induced by the Pten-Akt pathway is required for 
lactation initiation and provides a direct link between the Akt and Stat5 pathways. 
Genes Dev 26:2154-2168. 
Choi, et al., 2009. Elf5 conditional knockout mice reveal its role as a master regulator in 
mammary alveolar development: Failure of Stat5 activation and functional 
differentiation in the absence of Elf5. Dev Biol 329:227-241. 
Cid, et al., 2002. Estrogens and the vascular endothelium. Ann N Y Acad Sci 
966:143–157. 
Clarke, et al., 1997. Dissociation between steroid receptor expression and cell 
proliferation in the human breast. Cancer Res 57:4987-4991. 
Clegg, 1981. Lipoprotein lipase. Localization on plasma membrane fragments from 
lactating rat mammary tissue. Biochim Biophys Acta 664(2):397–408. 
Collier, et al., 1977. Lactogenesis in explant cultures of mammary tissue from pregnant 
cows. Endocrinology 100(4):1192-1200. 
Creamer, et al., 2010. Stat5 promotes survival of mammary epithelial cells through 
transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol 30(12):2957-
2970. 
D’Cruz, et al., 2002. Persistent parity-induced changes in growth factors, TGF-beta 3, 
and differentiation in the rodent mammary gland. Mol Endocrinol 16(9):2034-2051. 
Daniel and Silberstein, 1987. Postnatal development of the rodent mammary gland. In 
Neville and Daniel, (eds.), The Mammary Gland: Development, Regulation, 
	  116 
 
and Function. New York: Plenum Press. 
Daugaard, et al., 2007. The heat shock protein 70 family: Highly homologous proteins 
with overlapping and distinct functions. FEBS Lett 581:3702-3710. 
Desrivieres, et al., 2003. Comparative proteomic analysis of proliferating and 
functionally differentiated mammary epithelial cells. Mol Cell Proteomics 2:1039-
1054. 
Djonov, et al., 2001. Vascular remodelling during the normal and malignant 
life cycle of the mammary gland. Microsc Res Tech 52:182-189. 
Dreyfuss, et al., 2002. Messenger-RNA-binding proteins and the messages they carry.  
Nat Rev Mol Cell Biol 3(3):195-205. 
Edery, et al., 1985. Regulation of estrogen and progesterone receptor levels in mouse 
mammary epithelial cells grown in serum-free collagen gel cultures. Endocrinology 
116:105–112. 
Elias et al., 1973. Changes in fat cell morphology during lactation in the mouse. Anat Rec 
177:533-548. 
Emerman and Vogl, 1986. Cell size and shape changes in the myoepithelium of the 
mammary gland during differentiation. Anat Rec 216:405-415. 
Fata, et al., 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential 
for mammary gland development. Cell 103:41-50. 
Faulkner and Peaker, 1987. Regulation of mammary glucose metabolism in lactation. In 
Neville and Daniel (eds.), The Mammary Gland: Development, Regulation and 
Function. New York: Plenum. 
Fendrick, et al., 1998. Mammary gland growth and development from the postnatal 
	  117 
 
period to postmenopause: Ovarian steroid receptor ontogeny and regulation in the 
mouse. J Mammary Gland Biol Neoplasia 3(1):7-22. 
Feng, et al., 1995. Glucocorticoid and progesterone inhibit involution and programmed 
cell death in the mouse mammary gland. J Cell Biol 131:1095–1103. 
Fernandez-Valdivia, et al., 2009. The RANKL signaling axis is sufficient to elicit ductal 
side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev 
Biol 328:127-139. 
Feuerrman et al., 2009. Mammary fat can adjust prolactin effect on mammary epithelial 
cells via leptin and estrogen. Int J Endocrinol 2009:427260. 
Flint and Vernon, 1998. Effects of food restriction on the responses of the mammary 
gland and adipose tissue to prolactin and growth hormone in the lactating rat. J 
Endocrinol 156:299–305. 
Freund, et al., 2012. Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell 
23(11):2066-2075. 
Fritz, et al., 2002. Rho GTPases in human breast tumours: expression and mutation 
analyses and correlation with clinical parameters. Br J Cancer 87:635–644. 
Ginger, et al., 2001. Persistent changes in gene expression induced by estrogen and 
progesterone in the rat mammary gland. Mol Endocrinol 15(11):1993-2009. 
Goldman, et al., 2002. Nuclear lamins: building blocks of nuclear architecture. Genes 
Dev 16:533-547. 
Gomme and McCann, 2005. Transferrin: structure, function and potential therapeutic 
actions. Drug Discov Today 10(4):267-73. 
Gooding, et al., 2010. Three-dimensional ultrasound imaging of mammary ducts in 
	  118 
 
lactating women: a feasibility study. J Ultrasound Med 29(1):95-103. 
Gors, et al., 2009 Technical note: Milk composition in mice - methodological aspects and 
effects of mouse strain and lactation day. J Dairy Sci 92(2):632-637. 
Gouon-Evans, et al., 2000. Postnatal mammary gland development requires macrophages 
and eosinophils. Development 127:2269-2282. 
Gouon-Evans, et al., 2002. Requirement of macrophages and eosinophils and their 
cytokines/chemokines for mammary gland development. Breast Cancer Res 4:155-
164. 
Hadsell and Bonnette, 2000. IGF and insulin action in the mammary gland: Lessons from 
transgenic and knockout models. J Mammary Gland Biol Neoplasia 5:19–30. 
Hassiotou and Geddes, 2013. Anatomy of the human mammary gland: Current status of 
knowledge. Clin Anat 26(1):29-48. 
He and Smith, 2009. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. 
Cell Mol Life Sci 66:1239-1256. 
Hennighausen and Sippel, 1982. Mouse whey acidic protein is a novel member of the 
family of 'four-disulfide core' proteins. Nucleic Acids Res 10(8):2677-2684. 
Mouse whey acidic protein is a novel member of the family of ‘four-disulfide core’ 
proteins. Nucl Acids Res 10(8):2677-2684. 
Hollman, 1974. Cytology and fine structure of the mammary gland. In Larson and Smith, 
(eds.), Lactation. New York: Academic Press. 
Hovey and Aimo, 2010. Diverse and active roles for adipocytes during mammary gland 
growth and function. J Mammary Gland Biol Neoplasia 15:279-290. 
	  119 
 
Hovey, et al., 1999. Regulation of mammary gland growth and morphogenesis by the 
mammary fat pad: A species comparison. J Mammary Gland Biol Neoplasia 4(1):53-
68. 
Hovey, et al., 2001. Transcriptional regulation of vascular endothelial growth factor 
expression in epithelial and stromal cells during mouse mammary gland development. 
Mol Endocrinol 15(5):819-831. 
Hovey, et al., 2003. Local insulin-like growth factor-II mediates prolactin-induced 
mammary gland development. Mol Endocrinol 17(3):460-471. 
Howard and Gusterson, 2000. Human breast development. J Mammary Gland Biol 
Neoplasia 5(2):119-137. 
Howe, et al., 2008. Big data: The future of biocuration. Nature 455(7209):47-50. 
Howlin, et al., 2006. Pubertal mammary gland development: Insights from mouse 
models. J Mammary Gland Biol Neoplasia 11:283-297. 
Humphreys, et al., 1996. Apoptosis in the terminal endbud of the murine mammary 
gland: a mechanism of ductal morphogenesis. Development 122:4013-4022. 
Hunziker and Kraehenbul, 1998. Epithelial transcytosis of immunoglobulins. J Mammary 
Gland Biol Neoplasia 3(3):287-302. 
Ingle, et al., 1972. Lipogenesis in the ruminant: in vitro study of tissue sites, carbon 
source and reducing equivalent generation for fatty acid synthesis. J Nutr 102:609-
616. 
Ito, et al., 2009. Sept8 controls the binding of vesicle-associated membrane protein 2 to 
synaptophysin. J Neurochem 108:867-880. 
Jenness, 1974. Biosynthesis and composition of milk. J Invest Dermatol 63:109-118. 
	  120 
 
Jenness, 1988. Composition of milk. In Wong, et al., (eds.), Fundamentals of Dairy 
Chemistry. Springer US. 
Jensen, et al., 1994. Regulation of lipoprotein lipase activity and mRNA in the mammary 
gland of the lactating mouse. Biochem J 298:321-327. 
Jensen, (ed.) 1995. Handbook of milk composition. San Diego: Academic Press. 
Johnsen, et al., 2009. Regulation of estrogen-dependent transcription by the LIM 
cofactors CLIM and RLIM in breast cancer. Cancer Res 69:128-136. 
Johnson, et al., 2001. Limits to sustained energy intake. I. Lactation in the laboratory 
mouse Mus musculus. J Exp Biol 204(Pt 11):1925-35. 
Kabmeyer, et al., 2009. New insights in vascular development: Vasculogenesis and 
endothelial progenitor cells. Anat Histol Embryol 38:1-11. 
Kalsheker, 1988. Alpha1-antitrypsin: Structure, function and molecular biology of the 
gene. Biosci Rep 9(2):129-138. 
Kamada and Miwa, 1992. A protein binding to CArG box motifs and to single-stranded 
DNA functions as a transcriptional repressor. Gene 119(2):229-236. 
Karg and Schams, 1974. Prolactin release in cattle. J Reprod Fert 39:463-472. 
Kelsey, et al., 1993. Reproductive factors and breast cancer. Epidemiol Rev 15(1):36-47. 
Kingsley-Kallesen, et al., 2002. The mineralocorticoid receptor may compensate for the 
loss of the glucocorticoid receptor at specific stages of mammary gland development. 
Mol Endocrinol 16:2008–2018. 
Kinsella and Whitehead, 1989. Proteins in whey: Chemical, physical, and functional 
properties. Adv Food Nutr Res 33.3: 437-438. 
	  121 
 
Kleinberg, 1997. Early mammary development: Growth hormone and IGF-1. J Mammary 
Gland Biol Neoplasia 2(1):49-57. 
Knight and Beever, 1994. Nutrient metabolism and utilization in the mammary gland. 
Livestock Prod Sci 39:129-137. 
Koll, et al., 1992. Antifolding activity of hsp60 couples protein import into the 
mitochondrial matrix with export to the intermembrane space. Cell 68:1163-1175. 
Koya, et al., 2000. Gelsolin inhibits apoptosis by blocking mitochondrial membrane 
potential loss and cytochrome c release. J Biol Chem 275:15343-15349. 
Koyama, et al., 2013. The nipple: A simple intersection of mammary gland and 
integument, but focal point of organ function. J Mammary Gland Biol Neoplasia 
18:121-131. 
Kuhn, et al., 1980. Lactose synthesis: The possibilities of regulation. J Dairy Sci 63:328-
336. 
Lambe, et al., 1994. Transient increase in the risk of breast cancer after giving birth. N 
Engl J Med 331:5-9. 
Lambe, et al., 1996. Parity, age at first and last birth, and risk of breast cancer: A 
population-based study in Sweden. Breast Cancer Res Treat 38(3):305-11. 
Lane-Clayton, 1926. A further report on cancer of the breast, with special reference to its 
associated antecedent conditions. In Rep Min Health No. 32. London: HM Stationery 
Office. 
Lascelles and Lee, 1978. Involution of the mammary gland. In Larson and Smith (eds.), 
Lactation - A Comprehensive Treatise, Vol. 4. New York: Academic Press. 
	  122 
 
Lattanzi, 2011. Prelamin A-mediated nuclear envelope dynamics in normal and 
laminopathic cells. Biochem Soc Trans 39:1698-1704. 
Lee, et al., 2013. Progesterone drives mammary secretory differentiation via RankL-
mediated induction of Elf5 in luminal progenitor cells. Development 140:1397-1401. 
Lilla and Werb, 2010. Mast cells contribute to the stromal microenvironment in 
mammary gland branching morphogenesis. Dev Biol 337:124-133. 
Lin, et al., 2004. Regulation of cell migration and survival by focal adhesion targeting of 
Lasp-1. J Cell Biol 165:421-432. 
Liu, et al., 1997. StatSa is mandatory for adult mammary gland development and 
lactogenesis. Genes Dev 11:179-186. 
Lonnerdal, 1985. Biochemistry and physiological function of human milk proteins. Am J 
Clin Nutr 42:1299-1317. 
Luhr, et al., 2012. Mammary fibroblasts regulate morphogenesis of normal and 
tumorigenic breast epithelial cells by mechanical and paracrine signals. Cancer Lett 
325:175-188. 
Lund, et al., 1996. Two distinct phases of apoptosis in mammary gland involution: 
proteinase-independent and -dependent pathways. Development 122:181-193. 
Ma, et al., 2002. Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking 
response element-binding protein. J Biol Chem 277:18010-18020. 
Ma, et al., 2006. Reproductive factors and breast cancer risk according to joint estrogen 
and progesterone receptor status: a meta-analysis of epidemiological studies. Breast 
Cancer Res 8:R43. 
	  123 
 
MacMahon, et al., 1970. Age at first birth and breast cancer risk. Bull World Health 
Organ 43(2):209-21. 
Mallepell, et al., 2006. Paracrine signaling through the epithelial estrogen receptor alpha 
is required for proliferation and morphogenesis in the mammary gland. PNAS 
103(7):2196-2201. 
Maller, et al., 2010. Extracellular matrix composition reveals complex and dynamic 
stromal-epithelial interactions in the mammary gland. J Mammary Gland Biol 
Neoplasia 15:301-318. 
May, 2013. Engaging students in a bioinformatics activity to introduce gene structure and 
function. J Micobiol Biol Educ 14(1):107-109. 
McCave, et al., 2010. The normal nicroenvironment directs mammary gland 
development. J Mammary Gland Biol Neoplasia 15:291-299. 
Mepham, (ed.), 1983. Biochemistry of lactation. Amsterdam; New York: Elsevier. 
Mezl and Knox, 1977. Metabolism of arginine in lactating rat mammary gland. Biochem 
J 164:105-113. 
Mikaelian, et al., 2006. Expression of terminal differentiation proteins defines stages of 
mouse mammary gland development. Vet Pathol 43:36-49. 
Moriera, et al., 2010. Tissue proteomics of the human mammary gland: Towards an 
abridged definition of the molecular phenotypes underlying epithelial normalcy. Mol 
Oncol 4:539-561. 
Morrison and Cutler, 2009. Mouse mammary epithelial cells form mammospheres during 
lactogenic differentiation. J Vis Exp (32). 
Naccarato, et al., 2003. Definition of the microvascular pattern of the normal human adult 
	  124 
 
mammary gland. J Anat 203:599-603. 
Nagato, et al., 1980. A scanning electron microscope study of myoepithelial cells in 
exocrine glands. Cell Tissue Res 209:1-10. 
Nemeth, et al., 2000. Golgi targeting of the GLUT1 glucose transporter in the lactating 
mouse mammary gland. Pediatr Res 47:444-450. 
Neville and Daniel, (eds.), 1987. The mammary gland: Development, regulation and 
function. New York: Plenum Press. 
Neville and Picciano, 1997. Regulation of milk lipid secretion and composition. Annu 
Rev Nutr 17:159-184. 
Neville, et al., 1998. The mammary fat pad. J Mammary Gland Biol Neoplasia 3(2):109-
116. 
Neville, et al., 2001. Lactogenesis. The transition from pregnancy to lactation. Pediatr 
Clin North Am 48(1):35-52. 
Neville, et al., 2002. Hormonal regulation of mammary differentiation and milk secretion. 
J Mammary Gland Biol Neoplasia 7(1):49-66. 
Nguyen and Neville, 1998. Tight junction regulation in the mammary gland. J Mammary 
Gland Biol Neoplasia 3(3):233-246. 
National Research Council (NRC), 2010. Bio2010: Transforming Undergraduate 
Education for Future Research Biologists. Washington, DC: The National Academies 
Press. 
Oakes, et al., 2006. The alveolar switch: coordinating the proliferative cues and cell fate 
decisions that drive the formation of lobuloalveoli from ductal epithelium. Breast 
Cancer Res 8(2):207. 
	  125 
 
Oakes, et al., 2008. The Ets transcription factor Elf5 specifies mammary alveolar cell 
fate. Genes Dev 22(5):581-586. 
Oka and Perry, 1974. Arginase affects lactogenesis through its influence on the 
biosynthesis of spermidine. Nature 250:660-661. 
Ormandy, et al., 1997. Mammary gland development in prolactin receptor knockout 
mice. J Mamm Gland Biol Neoplasia 2:355-364. 
Palmiter, 1969. Hormonal induction and regulation of lactose synthetase in mouse 
mammary gland. Biochem J 113:409-417. 
Papadopoulou, et al., 2012. Expression profile and interactions of hnRNP A3 within 
hnRNP/mRNP complexes in mammals. Arch Biochem Biophys 523:151-160. 
Parikh, et al., 2005. Prevention of N-methyl-N-nitrosourea-induced breast cancer by 
alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of 
AFP. Clin Cancer Res 11:8512-8520. 
Patel and Korotchkina, 2006. Regulation of the pyruvate dehydrogenase complex. 
Biochem Soc Trans 34:217-222. 
Pellegrino, et al., 1988. Differential expression of keratins 13 and 16 in normal 
epithelium, benign lesions, and ductal carcinomas of the human breast determined by 
the monoclonal antibody Ks8.12. Cancer Res 48:5831-5836. 
Plant and Barker-Gibbs, 2004. Neurobiological mechanisms of puberty in higher 
primates. Hum Reprod Update 10(1):67-77. 
Pollard and Henninghausen, 1994. Colony stimulating factor 1 is required for mammary 
gland development during pregnancy. Proc Natl Acad Sci 91:9312-9316. 
Porter, et al., 2000. K15 expression implies lateral differentiation within stratified 
	  126 
 
epithelial basal cells. Lab Invest 80(11):1701-1710. 
Quarrie, et al., 1995. Apoptosis in lactating and involuting mouse mammary tissue 
demonstrated by nick-end DNA labelling. Cell Tisssue Res 281:413-419. 
Rabbany, et al., 2003. Molecular pathways regulating mobilization of marrow-derived 
stem cells for tissue revascularization. Trends Mol Med 9(3):109-117. 
Ramamoorthy, et al., 2010. Isoform-specific degradation of PR-B by E6-AP is critical for 
normal mammary gland development. Mol Endocrinol 24:2099–2113. 
Ramsay, et al., 2005. Anatomy of the lactating human breast redefined with ultrasound 
imaging. J Anat 206:525-534. 
Reece, 2009. Lactation. In Funcitonal Anatomy and Physiology of Domestic Animals. 
John Wiley & Sons. 
Richert, et al., 2000. An atlas of mouse mammary gland development. J Mammary Gland 
Biol Neoplasia 5(2):227-241. 
Rosen, et al., 1999. Regulation of milk protein gene expression. Annu Rev Nutr 19:407–
436. 
Rostovtseva and Bezrukov, 2008. VDAC regulation: Role of cytosolic proteins and 
mitochondrial lipids. J Bioenerg Biomembr 40(3):163-170. 
Ruan, et al., 1995. Estradiol enhances the stimulatory effect of insulin-like growth factor-
1 (IGF-1) on mammary development and growth hormone induced IGF-1 messenger 
ribonucleic acid. Endocrinology 136:1296-1302. 
Rudolph, et al., 2007. Metabolic regulation in the lactating mammary gland: A lipid  
synthesizing machine. Physiol Genomics 28:323-336. 
	  127 
 
Rudolph, et al., 2011. Prolactin-mediated regulation of lipid biosynthesis genes in vivo in 
the lactating mammary epithelial cell. Am J Physiol Endocrinol Metab 300:E1059-
E1068. 
Russo, et al., 1999. Pattern of distribution of cells positive for estrogen receptor alpha and 
progesterone receptor in relation to proliferating cells in the mammary gland. Breast 
Cancer Res Treat 53(3):217-227. 
Sadaie et al., 2013.  Redistribution of the Lamin B1 genomic binding profile affects 
rearrangement of heterochromatic domains and SAHF formation during senescence. 
Genes Dev 27:1800-1808. 
Sakai, et al., 1979. Glucocorticoid regulation of prolactin receptors on mammary cells in 
culture. Endocrinology 104:1447–1449. 
Salway, 1994. Metabolism at a glance. Blackwell Publishing, Ltd. 
Sans, et al., 2006. MondoA-Mlx heterodimers are candidate sensors of cellular energy 
status: Mitochondrial localization and direct regulation of glycolysis. Mol Cell Biol 
26(13):4863-4871. 
Schedin, et al., 2000. Estrous cycle regulation of mammary epithelial cell proliferation, 
differentiation, and death in the Sprague-Dawley rat: A model for investigating the 
role of estrous cycling in mammary carcinogenesis. J Mammary Gland Biol 
Neoplasia 5(2):211-225. 
Shi, et al., 2004. Hormonal defect in maspin heterozygous mice reveals a role of 
progesterone in pubertal ductal development. Mol Endocrinol 18(9):2196-2207. 
Shiryaev, et al., 2012. Septin 8 is an interaction partner and in vitro substrate of MK5. 
World J Biol Chem 3(5):98-109. 
	  128 
 
SILS, 2013. “Bioinformatics – Academic Degree Programs.” Informatics Degree 
Program Summary. UNC – School of Information and Library Science. Web. 11 
October 2013. <http://ils.unc.edu/informatics_programs/index.php>. 
Simian, et al., 2001. The interplay of matrix metalloproteinases, morphogens and growth 
factors is necessary for branching of mammary epithelial cells. Development 
128(16):3117-3131. 
Srivastava, et al., 2003. Receptor activator of NF-kB ligand induction via Jak2 and Stat5a 
in mammary epithelial cells. J Biol Chem 278:46171-46178. 
Stark, et al., 1997. Visualization of elongation factor Tu on the Escherichia coli 
ribosome. Nature 389(6649):403-406. 
Stein, et al., 2007. Mammary gland involution as a multi-step process. J Mammary Gland 
Biol Neoplasia 12:25-35. 
Stelwagen, et al., 2009. Immune components of bovine colostrum and milk. J Anim Sci 
87:3-9. 
Sternlicht, et al., 2005. Mammary ductal morphogenesis requires paracrine activation of 
stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. 
Development 132(17):3923-3933. 
Sternlicht, 2005. Key stages in mammary gland development: The cues that regulate 
ductal branching morphogenesis. Breast Cancer Res 8(1):201. 
Strand, 2012. A proteomic analysis of differentiation in the mammary epithelium. 
Unpublished thesis.  
Thompson, et al., (eds.), 2009. Milk Proteins: From Expression to Food. New York: 
Academic Press. 
	  129 
 
Toogood, et al., 2007. Dynamics driving function: new insights from electron transferring 
flavoproteins and partner complexes. FEBS J 274(21):5481-5504. 
Treiber, et al., 2012. Regulation of microRNA biogenesis and function. Thromb Haemost 
107(4):605-610. 
Trott, et al., 2012. Triennial lactation symposium: Prolactin: The multifaceted potentiator 
of mammary growth and function. J Anim Sci 90:1674-1686. 
Turkington, et al., 1968. The hormonal control of lactose synthetase in the developing 
mouse mammary gland. J Biol Chem 243:3382-3387. 
Vakharia and Mizejewski, 2000. Human alpha-fetoprotein peptides bind estrogen 
receptor and estradiol and suppress breast cancer. Breast Cancer Res Treat 63:41-52. 
Vernon, 1989. Endocrine control of metabolic adaptation during lactation. Proc Nutr Soc 
48:23-32. 
Wainwright, 1931. Comparison of conditions associated with breast cancer in Great 
Britain and America. Am J Cancer 15:2610-2645. 
Walden, et al., 1998. Evidence that the mammary fat pad mediates the action of growth 
hormone in mammary gland development. Endocrinology 139(2):659-662. 
Wang and Oster, 1998. Energy transduction in the F1 motor of ATP synthase. Nature 
396(6708):279-282. 
Waseem, et al., 1999. Keratin 15 expression in stratified epithelia: Downregulation in 
activated keratinocytes. J Invest Dermatol 112:362–369. 
Watson, 2006. Involution: Apoptosis and tissue remodeling that convert the mammary 
gland from milk factory to a quiescent organ. Breast Cancer Res 8(2):203. 
	  130 
 
Weisz-Carrington, et al., 1977. Plasma cells and epithelial immunoglobulins in the mouse 
mammary gland during pregnancy and lactation. J Immunol 119(4):1306-1309. 
Welsh, et al., 2003. Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 
133:2425S–33S. 
Wiesen et al., 1999. Signaling through the stromal epidermal growth factor receptor is 
necessary for mammary ductal development. Development 126:335-344. 
Williams and Daniel, 1983. Mammary ductal elongation: Differentiation of 
myoepithelium and basal lamina during branching morphogenesis. Dev Biol 97:274-
290. 
Wolkenhauer and Hofmeyr, 2013. Interdisciplinarity as both necessity and hurdle for 
progress in the life sciences. In Andersen, et al., (eds.), New Challenges to Philosophy 
of Science - The Philosophy of Science in a European perspective 4. Amsterdam, The 
Netherlands: Springer Verlag. 
Wood, et al., 2000. The insulin-like growth factors (IGFs) and IGF binding proteins in 
postnatal development of murine mammary glands. J Mammary Gland Biol 
Neoplasia 5:31–42. 
Yang, et al., 2009. Regulation of β4-integrin expression by epigenetic modifications in 
the mammary gland and during the epithelial-to-mesenchymal transition.  J Cell Sci 
122(14): 2473–2480. 
Yip and Knox, 1972. Function of arginase in lactating mammary gland. Biochem J 
127:893-899. 
	  131 
 
Yoshida, et al., 2013. Molecular chaperone TRAP1 regulates a metabolic switch between 
mitochondrial respiration and aerobic glycolysis. Proc Natl Acad Sci U S A 
110(17):E1604-E1612. 
Zinger, et al., 2003. Prolactin expression and secretion by human breast glandular and 
adipose tissue explants. J Clin Endocrinol Metab 88(2):689-696. 
Zinser, et al., 2002. Vitamin D(3) receptor ablation alters mammary gland 
morphogenesis. Development 129:3067–3076. 
  
	  132 
 
APPENDIX A – Use Case Document from CSC 366 
 
 
 
	  133 
 
 
	  134 
 
	  
	  135 
 
	  
	  136 
 
	  137 
 
	  	  	  
	  138 
 
	  139 
 
	  
	  140 
 
	  
	  141 
 
	  
	  142 
 
 
